Adenocarcinoma and papillary adenocarcinoma of stomach

C3_STOMACH_ADENO

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cancer registry: Topography ICD-O-3 — C16 Cancer registry: Morphology ICD-O-3 — 8140\|8145 Cancer registry: Behaviour codes — 3 1 out of 7 registries used, show all original rules.	1144
4. Check minimum number of events None	1144
5. Include endpoints None	1144
6. Filter based on genotype QC (FinnGen only)	1104

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF8

NAME	C3_STOMACH_ADENO
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C16
CANC_TOPO_EXCL
CANC_MORPH	8140\|8145
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Adenocarcinoma and papillary adenocarcinoma of stomach based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1104	320	784
Unadjusted period prevalence (%)	0.29	0.11	0.36
Median age at first event (years)	67.93	65.38	68.97

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1144: Matched controls
11440

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

ZXD05, ,

ICD-O-3

+∞

322.6

294

M01AE03, ,

ATC

ketoprofen; systemic, rectal

+∞

320.3

292

R05FA02, ,

ATC

opium derivatives and expectorants; systemic

+∞

318.0

290

WX408, ,

ICD-O-3

+∞

316.8

289

R104, ,

ICD-10 Finland

Other and unspecified abdominal pain

+∞

315.7

288

TPH04, ,

ICD-O-3

+∞

311.1

284

JN4BD, ,

ICD-O-3

+∞

308.7

282

M01AB05, ,

ATC

diclofenac; systemic, rectal

+∞

307.7

446

B03BA03, ,

ATC

hydroxocobalamin; parenteral

+∞

307.7

430

M01AE01, ,

ATC

ibuprofen; systemic, rectal

+∞

307.7

674

EB1AA, ,

ICD-O-3

+∞

307.7

309

ZXE10, ,

ICD-O-3

+∞

307.7

311

N05CF01, ,

ATC

zopiclone; oral

+∞

307.7

363

R05FB02, ,

ATC

cough suppressants and expectorants; systemic

+∞

307.7

305

A12AX, ,

ATC

Calcium, combinations with vitamin D and/or other drugs

+∞

307.7

306

SAA02, ,

ICD-O-3

+∞

307.7

334

WZC00, ,

ICD-O-3

+∞

307.7

419

C169, ,

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

307.7

424

ZXE00, ,

ICD-O-3

+∞

307.7

337

SFA10, ,

ICD-O-3

+∞

307.7

295

N02AX02, ,

ATC

tramadol; systemic, rectal

+∞

307.7

467

N02AA05, ,

ATC

oxycodone; systemic

+∞

307.7

420

C10AA01, ,

ATC

simvastatin; oral

+∞

307.7

359

K021, ,

ICD-O-3

+∞

307.7

304

C03CA01, ,

ATC

furosemide; systemic

+∞

307.7

317

A02BC02, ,

ATC

pantoprazole; systemic

+∞

307.7

787

GD1AA, ,

ICD-O-3

+∞

307.7

491

R03AC02, ,

ATC

salbutamol; inhalant

+∞

307.7

319

M01AH05, ,

ATC

etoricoxib; oral

+∞

307.7

300

M01AE02, ,

ATC

naproxen; oral, rectal

+∞

307.7

364

ZXD10, ,

ICD-O-3

+∞

307.7

326

A04AA02, ,

ATC

granisetron; systemic, transdermal

+∞

307.7

325

I10, ,

ICD-10 Finland

Essential (primary) hypertension

+∞

307.7

382

L01BC06, ,

ATC

capecitabine; oral

+∞

307.7

340

A98, ,

ICD-O-3

+∞

307.7

660

J01AA02, ,

ATC

doxycycline; systemic

+∞

307.7

653

SAA01, ,

ICD-O-3

+∞

307.7

408

J01CA04, ,

ATC

amoxicillin; systemic

+∞

307.7

606

J01FA10, ,

ATC

azithromycin; systemic

+∞

307.7

306

SFA20, ,

ICD-O-3

+∞

307.7

309

J01MA02, ,

ATC

ciprofloxacin; systemic

+∞

307.7

341

C07AB07, ,

ATC

bisoprolol; oral

+∞

307.7

416

J01CR02, ,

ATC

amoxicillin and beta-lactamase inhibitor; systemic

+∞

307.7

370

M03BX02, ,

ATC

tizanidine; oral

+∞

307.7

373

C160, 8140, 3

+∞

307.7

297

H02AB06, ,

ATC

prednisolone; systemic

+∞

307.7

342

UJD10, ,

ICD-O-3

+∞

307.7

797

E0000UV, ,

ATC

+∞

307.7

327

C169, 8140, 3

+∞

307.7

304

S18, ,

ICD-O-3

+∞

307.7

320

A02BC05, ,

ATC

esomeprazole; systemic

+∞

307.7

406

A03FA01, ,

ATC

metoclopramide; systemic, rectal

+∞

307.7

669

WX110, ,

ICD-O-3

+∞

307.7

535

J01CE02, ,

ATC

phenoxymethylpenicillin; oral

+∞

307.7

469

J01DA01, ,

ATC

[U] cefalexin

+∞

307.7

537

B01AB05, ,

ATC

enoxaparin; parenteral

+∞

307.7

432

A02BC03, ,

ATC

lansoprazole; oral

+∞

307.7

321

H02AB02, ,

ATC

dexamethasone; systemic

+∞

307.7

433

130, ,

Kela drug reimbursment

Malignant tumour

+∞

307.7

678

SPAT1256, ,

ICD-O-3

+∞

307.7

361

J01DB01, ,

ATC

cefalexin; oral

+∞

307.7

646

107, ,

Kela drug reimbursment

Pernicious anaemia

+∞

307.7

351

N02BE01, ,

ATC

paracetamol; systemic, rectal

+∞

307.7

751

N02AA59, ,

ATC

codeine, combinations excl. psycholeptics; systemic

+∞

307.6

281

A02BC01, ,

ATC

omeprazole; systemic

+∞

307.6

281

Z515, ,

ICD-10 Finland

Palliative care

+∞

307.6

281

R06AE07, ,

ATC

cetirizine; oral

+∞

305.3

279

WYA05, ,

ICD-O-3

+∞

304.1

278

SPAT1263, ,

ICD-O-3

+∞

303.0

277

P01AB01, ,

ATC

metronidazole; oral, rectal

+∞

300.7

275

205, ,

Kela drug reimbursment

Chronic hypertension

+∞

299.5

274

R4110, ,

ICD-O-3

+∞

298.4

273

KMAK, ,

ICD-O-3

+∞

294.9

270

601, ,

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

+∞

293.8

269

J01FA06, ,

ATC

roxithromycin; oral

+∞

286.9

263

JDD00, ,

ICD-O-3

+∞

286.9

263

J189, ,

ICD-10 Finland

Pneumonia, unspecified

+∞

283.5

260

M02AA07, ,

ATC

piroxicam; topical

+∞

282.3

259

G04CA02, ,

ATC

tamsulosin; oral

+∞

281.2

258

I10, ,

ICD-O-3

+∞

280.0

257

S01XA20, ,

ATC

artificial tears and other indifferent preparations; ophthalmic

+∞

278.9

256

UJF32, ,

ICD-O-3

+∞

276.6

254

N06AX11, ,

ATC

mirtazapine; oral

+∞

275.5

253

S01CA01, ,

ATC

dexamethasone and antiinfectives; ophthalmic

+∞

270.9

249

GD1UA, ,

ICD-O-3

+∞

269.8

248

WD125, ,

ICD-O-3

+∞

268.6

247

B81, ,

ICD-O-3

+∞

266.4

245

WX402, ,

ICD-O-3

+∞

265.2

244

WX302, ,

ICD-O-3

+∞

264.1

243

C08CA01, ,

ATC

amlodipine; oral

+∞

260.7

240

SPAT1249, ,

ICD-O-3

+∞

259.5

239

SPAT1153, ,

ICD-O-3

+∞

259.5

239

CJE20, ,

ICD-O-3

+∞

259.5

239

SPAT1325, ,

ICD-O-3

+∞

252.7

233

C169, 8145, 3

+∞

251.6

232

EB1HA, ,

ICD-O-3

+∞

250.5

231

C10AA05, ,

ATC

atorvastatin; oral

+∞

247.1

228

WZC30, ,

ICD-O-3

+∞

246.0

227

SPAT1301, ,

ICD-O-3

+∞

246.0

227

R01AD09, ,

ATC

mometasone; nasal

+∞

244.8

226

SFA30, ,

ICD-O-3

+∞

244.8

226

A10BA02, ,

ATC

metformin; oral

+∞

243.7

225

N02AJ06, ,

ATC

codeine and paracetamol; systemic

+∞

241.4

223

M01AC06, ,

ATC

meloxicam; systemic, rectal

+∞

240.3

222

103, ,

Kela drug reimbursment

Diabetes, insulin-treated

+∞

239.2

221

A04AA01, ,

ATC

ondansetron; systemic, rectal

+∞

238.1

220

C01DA02, ,

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

+∞

233.6

216

D07AC01, ,

ATC

betamethasone; topical

+∞

232.4

215

JN4AD, ,

ICD-O-3

+∞

232.4

215

W01, ,

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

+∞

231.3

214

Z871, ,

ICD-O-3

+∞

230.2

213

EBA00, ,

ICD-O-3

+∞

229.1

212

C1600, ,

ICD-10 Finland

Cardia

+∞

229.1

212

H251, ,

ICD-10 Finland

Senile nuclear cataract

+∞

225.7

209

J02AC01, ,

ATC

fluconazole; systemic

+∞

224.6

208

J01MA12, ,

ATC

levofloxacin; systemic

+∞

224.6

208

A06AD11, ,

ATC

lactulose; oral

+∞

220.1

204

-1, ,

ICD-O-3

+∞

217.9

202

A02BA02, ,

ATC

ranitidine; systemic

+∞

215.6

200

WX290, ,

ICD-O-3

+∞

215.6

200

N05BA04, ,

ATC

oxazepam; oral

+∞

213.4

198

TPH07, ,

ICD-O-3

+∞

213.4

198

Z3231, ,

ICD-O-3

+∞

211.2

196

I251, ,

ICD-10 Finland

Atherosclerotic heart disease

+∞

211.2

196

C155, ,

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

211.2

196

SPAT1250, ,

ICD-O-3

+∞

210.0

195

N03AX16, ,

ATC

[U] pregabalin

+∞

208.9

194

SPAT1253, ,

ICD-O-3

+∞

208.9

194

WX002, ,

ICD-O-3

+∞

207.8

193

I48, ,

ICD-10 Finland

Atrial fibrillation and flutter

+∞

206.7

192

C09AA05, ,

ATC

ramipril; oral

+∞

206.7

192

C07AB02, ,

ATC

metoprolol; systemic

+∞

203.4

189

SAA03, ,

ICD-O-3

+∞

203.4

189

Z012, ,

ICD-O-3

+∞

203.4

189

ZXA00, ,

ICD-O-3

+∞

202.2

188

TPH15, ,

ICD-O-3

+∞

202.2

188

N02AB03, ,

ATC

fentanyl; nasal, sublingual, transdermal

+∞

201.1

187

J01DA09, ,

ATC

[U] cefadroxil

+∞

200.0

186

C01DA08, ,

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

+∞

200.0

186

206, ,

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

+∞

198.9

185

J01CA08, ,

ATC

pivmecillinam; oral

+∞

198.9

185

B01AA03, ,

ATC

warfarin; systemic

+∞

196.7

183

J01FF01, ,

ATC

clindamycin; systemic

+∞

196.7

183

D07AC13, ,

ATC

mometasone; topical

+∞

194.5

181

Z2221, ,

ICD-O-3

+∞

194.5

181

EB1SA, ,

ICD-O-3

+∞

194.5

181

C160, ,

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

193.4

180

FM1EE, ,

ICD-O-3

+∞

192.2

179

ZXE20, ,

ICD-O-3

+∞

191.1

178

G03CA03, ,

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

+∞

188.9

176

ZXA05, ,

ICD-O-3

+∞

187.8

175

WX602, ,

ICD-O-3

+∞

187.8

175

AA1AD, ,

ICD-O-3

+∞

187.8

175

M01AX17, ,

ATC

nimesulide; oral

+∞

186.7

174

WB113, ,

ICD-O-3

+∞

186.7

174

R4190, ,

ICD-O-3

+∞

185.6

173

J01EE02, ,

ATC

sulfadiazine and trimethoprim; systemic

+∞

184.5

172

D07AB02, ,

ATC

hydrocortisone butyrate; topical

+∞

183.4

171

WX404, ,

ICD-O-3

+∞

183.4

171

J01FA09, ,

ATC

clarithromycin; systemic

+∞

183.4

171

SPAT1310, ,

ICD-O-3

+∞

181.2

169

E119, ,

ICD-10 Finland

Type 2 diabetes mellitus, without complications

+∞

180.1

168

WZB00, ,

ICD-O-3

+∞

179.0

167

D01BA02, ,

ATC

terbinafine; oral

+∞

174.6

163

Z024, ,

ICD-O-3

+∞

173.5

162

C09AA02, ,

ATC

enalapril; systemic

+∞

172.4

161

SFC01, ,

ICD-O-3

+∞

172.4

161

C798, ,

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

168.0

157

C1609, ,

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

165.8

155

N40, ,

ICD-10 Finland

Hyperplasia of prostate

+∞

165.8

155

R01BA52, ,

ATC

pseudoephedrine, combinations; oral

+∞

165.8

155

R05DA20, ,

ATC

opium alkaloids and derivatives - combinations

+∞

163.6

153

A499, ,

ICD-10 Finland

Bacterial infection, unspecified

+∞

163.6

153

A28, ,

ICD-O-3

+∞

163.6

153

GD1QA, ,

ICD-O-3

+∞

162.5

152

C162, ,

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

162.5

152

SPAT1223, ,

ICD-O-3

+∞

161.4

151

215, ,

Kela drug reimbursment

Diabetes, non-insulin-treated

+∞

161.4

151

XF400, ,

ICD-O-3

+∞

160.3

150

FN1AC, ,

ICD-O-3

+∞

160.3

150

SPAT1312, ,

ICD-O-3

+∞

160.3

150

D649, ,

ICD-10 Finland

Anaemia, unspecified

+∞

160.3

150

C01DA14, ,

ATC

isosorbide mononitrate; oral

+∞

159.2

149

D82, ,

ICD-O-3

+∞

157.0

147

C1623, ,

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

157.0

147

A06AC01, ,

ATC

ispaghula (psylla seeds); oral

+∞

157.0

147

T90, ,

ICD-O-3

+∞

155.9

146

SDA02, ,

ICD-O-3

+∞

154.8

145

Z3226, ,

ICD-O-3

+∞

154.8

145

ZX120, ,

ICD-O-3

+∞

153.7

144

D01AC20, ,

ATC

imidazoles/triazoles in combination with corticosteroids; topical

+∞

153.7

144

M796, ,

ICD-O-3

+∞

152.6

143

WX700, ,

ICD-O-3

+∞

151.5

142

TPX10, ,

ICD-O-3

+∞

151.5

142

JN3BD, ,

ICD-O-3

+∞

150.4

141

D371, ,

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

+∞

150.4

141

R074, ,

ICD-10 Finland

Chest pain, unspecified

+∞

150.4

141

JN3AE, ,

ICD-O-3

+∞

149.3

140

JAH01, ,

ICD-O-3

+∞

148.2

139

R509, ,

ICD-10 Finland

Fever, unspecified

+∞

146.0

137

M545, ,

ICD-O-3

+∞

146.0

137

WD105, ,

ICD-O-3

+∞

144.9

136

M03BC51, ,

ATC

orphenadrine, combinations; systemic

+∞

144.9

136

SPAT1254, ,

ICD-O-3

+∞

144.9

136

C168, ,

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

143.9

135

K045, ,

ICD-O-3

+∞

143.9

135

SPAT1262, ,

ICD-O-3

+∞

142.8

134

203, ,

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

+∞

141.7

133

SDA03, ,

ICD-O-3

+∞

141.7

133

N06AB04, ,

ATC

citalopram; systemic

+∞

141.7

133

J01EA01, ,

ATC

trimethoprim; systemic

+∞

140.6

132

N05CD07, ,

ATC

temazepam; oral

+∞

139.5

131

R05, ,

ICD-O-3

+∞

139.5

131

C09CA01, ,

ATC

losartan; oral

+∞

138.4

130

FM1AE, ,

ICD-O-3

+∞

138.4

130

JN3AD, ,

ICD-O-3

+∞

137.3

129

UJD02, ,

ICD-O-3

+∞

137.3

129

SFA40, ,

ICD-O-3

+∞

137.3

129

WX320, ,

ICD-O-3

+∞

135.1

127

Z018, ,

ICD-10 Finland

Other specified special examinations

+∞

135.1

127

J069, ,

ICD-O-3

+∞

134.0

126

H03AA01, ,

ATC

levothyroxine sodium; systemic

+∞

133.0

125

R11, ,

ICD-10 Finland

Nausea and vomiting

+∞

133.0

125

WB121, ,

ICD-O-3

+∞

133.0

125

B01AB10, ,

ATC

tinzaparin; parenteral

+∞

131.9

124

C10AA07, ,

ATC

rosuvastatin; oral

+∞

130.8

123

Z713, ,

ICD-10 Finland

Dietary counselling and surveillance

+∞

129.7

122

ZXA10, ,

ICD-O-3

+∞

129.7

122

M01AX05, ,

ATC

glucosamine; oral

+∞

127.5

120

H13, ,

ICD-O-3

+∞

126.4

119

UKC02, ,

ICD-O-3

+∞

126.4

119

R53, ,

ICD-10 Finland

Malaise and fatigue

+∞

125.4

118

L17, ,

ICD-O-3

+∞

125.4

118

GD1PA, ,

ICD-O-3

+∞

124.3

117

207, ,

Kela drug reimbursment

Chronic arrhythmias

+∞

124.3

117

SPAT1033, ,

ICD-O-3

+∞

124.3

117

E000001, ,

ATC

+∞

124.3

117

EBA05, ,

ICD-O-3

+∞

123.2

116

XKD00, ,

ICD-O-3

+∞

122.1

115

R060, ,

ICD-10 Finland

Dyspnoea

+∞

122.1

115

H903, ,

ICD-10 Finland

Sensorineural hearing loss, bilateral

+∞

122.1

115

XX3DW, ,

ICD-O-3

+∞

122.1

115

SPAT1222, ,

ICD-O-3

+∞

122.1

115

JCF12, ,

ICD-O-3

+∞

121.0

114

R104, ,

ICD-O-3

+∞

121.0

114

L28, ,

ICD-O-3

+∞

121.0

114

WZA90, ,

ICD-O-3

+∞

119.9

113

JDW98, ,

ICD-O-3

+∞

119.9

113

R01AD08, ,

ATC

fluticasone; nasal

+∞

119.9

113

K573, ,

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

+∞

119.9

113

N02AE01, ,

ATC

buprenorphine; parenteral, sublingual, transdermal

+∞

117.8

111

C03EA01, ,

ATC

hydrochlorothiazide and potassium-sparing agents; oral

+∞

116.7

110

JAH00, ,

ICD-O-3

+∞

116.7

110

A04, ,

ICD-O-3

+∞

115.6

109

L03, ,

ICD-O-3

+∞

115.6

109

D509, ,

ICD-10 Finland

Iron deficiency anaemia, unspecified

+∞

113.5

107

65000, ,

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

+∞

113.5

107

J05AB01, ,

ATC

aciclovir; systemic

+∞

112.4

106

B01AC04, ,

ATC

clopidogrel; oral

+∞

112.4

106

SPAT1230, ,

ICD-O-3

+∞

111.3

105

Z718, ,

ICD-10 Finland

Other specified counselling

+∞

111.3

105

SPAT1260, ,

ICD-O-3

+∞

111.3

105

S29, ,

ICD-O-3

+∞

110.2

104

R01AD12, ,

ATC

fluticasone furoate; nasal

+∞

109.1

103

M01AH01, ,

ATC

celecoxib; oral

+∞

109.1

103

L15, ,

ICD-O-3

+∞

108.1

102

B01AB04, ,

ATC

dalteparin; parenteral

+∞

108.1

102

N05CF02, ,

ATC

zolpidem; oral

+∞

108.1

102

C1620, ,

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

108.1

102

Z515, ,

ICD-O-3

+∞

107.0

101

JN4CD, ,

ICD-O-3

+∞

107.0

101

K409, ,

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

+∞

107.0

101

R91, ,

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

+∞

107.0

101

M02AA10, ,

ATC

ketoprofen; topical

+∞

107.0

101

G04CB01, ,

ATC

finasteride; oral

+∞

105.9

100

N10, ,

ICD-10 Finland

Acute tubulo-interstitial nephritis

+∞

105.9

100

A04AA55, ,

ATC

palonosetron, combinations; systemic

+∞

104.8

E7801, ,

ICD-10 Finland

Pure hypercholesterolaemia

+∞

104.8

J448, ,

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

+∞

104.8

D19, ,

ICD-O-3

+∞

104.8

VALMI, ,

ICD-O-3

+∞

104.8

M796, ,

ICD-10 Finland

Pain in limb

+∞

103.7

K921, ,

ICD-10 Finland

Melaena

+∞

103.7

C163, ,

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

103.7

UGC12, ,

ICD-O-3

+∞

103.7

R13, ,

ICD-10 Finland

Dysphagia

+∞

103.7

C1633, ,

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

102.7

I509, ,

ICD-10 Finland

Heart failure, unspecified

+∞

102.7

JCC12, ,

ICD-O-3

+∞

102.7

E11, ,

ICD-O-3

+∞

101.6

C09CA06, ,

ATC

candesartan; oral

+∞

101.6

N05BA01, ,

ATC

diazepam; systemic, rectal

+∞

101.6

WZC20, ,

ICD-O-3

+∞

101.6

T814, ,

ICD-10 Finland

Infection following a procedure, not elsewhere classified

+∞

100.5

SDA01, ,

ICD-O-3

+∞

100.5

H81, ,

ICD-O-3

+∞

100.5

Z039, ,

ICD-10 Finland

Observation for suspected disease or condition, unspecified

+∞

100.5

SCA01, ,

ICD-O-3

+∞

100.5

I48, ,

ICD-O-3

+∞

100.5

J459, ,

ICD-10 Finland

Asthma, unspecified

+∞

100.5

A29, ,

ICD-O-3

+∞

100.5

JKA20, ,

ICD-O-3

+∞

99.4

R42, ,

ICD-10 Finland

Dizziness and giddiness

+∞

99.4

290, ,

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

99.4

Z712, ,

ICD-O-3

+∞

99.4

K566, ,

ICD-10 Finland

Other and unspecified intestinal obstruction

+∞

99.4

TPH20, ,

ICD-O-3

+∞

99.4

C1603, ,

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

+∞

99.4

KC1EE, ,

ICD-O-3

+∞

99.4

C07AA05, ,

ATC

propranolol; systemic

+∞

99.4

J159, ,

ICD-10 Finland

Bacterial pneumonia, unspecified

+∞

99.4

N05AH04, ,

ATC

quetiapine; oral

+∞

99.4

SDE02, ,

ICD-O-3

+∞

98.4

R03AK06, ,

ATC

salmeterol and fluticasone; inhalant

+∞

97.3

A09, ,

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

+∞

97.3

C1639, ,

ICD-10 Finland

Malignant tumor of the antrum ventriculi other or unspecified carcinoma

+∞

97.3

J01DA06, ,

ATC

[U] cefuroxime

+∞

96.2

E119, ,

ICD-O-3

+∞

96.2

SDE03, ,

ICD-O-3

+∞

96.2

M171, ,

ICD-10 Finland

Other primary gonarthrosis

+∞

95.1

SPAT1216, ,

ICD-O-3

+∞

94.1

SPAT1097, ,

ICD-O-3

+∞

94.1

M04AA01, ,

ATC

allopurinol; systemic

+∞

94.1

L08, ,

ICD-O-3

+∞

93.0

R74, ,

ICD-O-3

+∞

93.0

J02AC02, ,

ATC

itraconazole; systemic

+∞

93.0

C01AA05, ,

ATC

digoxin; systemic

+∞

93.0

L03AA02, ,

ATC

filgrastim; parenteral

+∞

93.0

H02AB07, ,

ATC

prednisone; oral

+∞

93.0

X59, ,

ICD-10 Finland

Exposure to unspecified factor

+∞

93.0

C1630, ,

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

90.9

A03FA02, ,

ATC

cisapride; oral, rectal

+∞

90.9

R53, ,

ICD-O-3

+∞

89.8

R101, ,

ICD-O-3

+∞

89.8

C03DA01, ,

ATC

spironolactone; oral

+∞

89.8

K85, ,

ICD-O-3

+∞

89.8

C05AA08, ,

ATC

fluocortolone; rectal, topical

+∞

88.7

M03BC01, ,

ATC

orphenadrine (citrate); systemic

+∞

88.7

G04CA01, ,

ATC

alfuzosin; oral

+∞

88.7

M01AC01, ,

ATC

piroxicam; systemic, rectal

+∞

88.7

AN1, ,

ICD-O-3

+∞

87.6

I259, ,

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

+∞

87.6

K0364, ,

ICD-O-3

+∞

87.6

R03BA01, ,

ATC

beclometasone; inhalant

+∞

87.6

G473, ,

ICD-10 Finland

Sleep apnoea

+∞

87.6

SPAT1149, ,

ICD-O-3

+∞

87.6

WX704, ,

ICD-O-3

+∞

86.6

D07AA02, ,

ATC

hydrocortisone; topical

+∞

86.6

R101, ,

ICD-10 Finland

Pain localized to upper abdomen

+∞

86.6

A97, ,

ICD-O-3

+∞

86.6

JN1AE, ,

ICD-O-3

+∞

86.6

JN3AA, ,

ICD-O-3

+∞

86.6

SPAT1306, ,

ICD-O-3

+∞

86.6

JC2AB, ,

ICD-O-3

+∞

86.6

I702, ,

ICD-10 Finland

Atherosclerosis of arteries of extremities

+∞

86.6

R060, ,

ICD-O-3

+∞

85.5

H02AB04, ,

ATC

methylprednisolone; systemic

+∞

85.5

Z961, ,

ICD-10 Finland

Presence of intraocular lens

+∞

85.5

C1629, ,

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

+∞

85.5

D01, ,

ICD-O-3

+∞

85.5

R06AX27, ,

ATC

desloratadine; oral

+∞

84.4

WW500, ,

ICD-O-3

+∞

84.4

L03AA13, ,

ATC

pegfilgrastim; parenteral

+∞

84.4

SDA04, ,

ICD-O-3

+∞

84.4

351, ,

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

83.4

K802, ,

ICD-10 Finland

Calculus of gallbladder without cholecystitis

+∞

83.4

Z010, ,

ICD-10 Finland

Examination of eyes and vision

+∞

83.4

JAB30, ,

ICD-O-3

+∞

83.4

C164, ,

ICD-10 Finland

Malignant neoplasm: Pylorus

+∞

83.4

ZXE30, ,

ICD-O-3

+∞

83.4

J189, ,

ICD-O-3

+∞

83.4

C169, ,

ICD-O-3

Stomach, NOS

+∞

82.3

WVA30, ,

ICD-O-3

+∞

82.3

SPAT1148, ,

ICD-O-3

+∞

82.3

A02BD03, ,

ATC

lansoprazole, amoxicillin and metronidazole; systemic

+∞

82.3

A02BA04, ,

ATC

nizatidine; systemic

+∞

82.3

N06AB10, ,

ATC

escitalopram; oral

+∞

82.3

R03AK07, ,

ATC

formoterol and budesonide; inhalant

+∞

81.2

R03BA05, ,

ATC

fluticasone; inhalant

+∞

81.2

R5110, ,

ICD-O-3

+∞

81.2

R03BB04, ,

ATC

tiotropium bromide; inhalant

+∞

80.2

R42, ,

ICD-O-3

+∞

80.2

Z048, ,

ICD-10 Finland

Examination and observation for other specified reasons

+∞

80.2

D07AD01, ,

ATC

clobetasol; topical

+∞

79.1

M01AH02, ,

ATC

rofecoxib; oral

+∞

79.1

A03, ,

ICD-O-3

+∞

79.1

M751, ,

ICD-O-3

+∞

79.1

C155, ,

ICD-O-3

Lower third of esophagus

+∞

78.0

B02AA02, ,

ATC

tranexamic acid; systemic

+∞

78.0

R03BA02, ,

ATC

budesonide; inhalant

+∞

78.0

D07BC01, ,

ATC

betamethasone and antiseptics; topical

+∞

78.0

SPAT1156, ,

ICD-O-3

+∞

78.0

D07CA01, ,

ATC

hydrocortisone and antibiotics; topical

+∞

77.0

M545, ,

ICD-10 Finland

Low back pain

+∞

77.0

Z760, ,

ICD-O-3

+∞

75.9

SPAT1255, ,

ICD-O-3

+∞

75.9

S21, ,

ICD-O-3

+∞

75.9

J01AA07, ,

ATC

tetracycline; systemic

+∞

74.8

A04AD12, ,

ATC

aprepitant; systemic

+∞

74.8

C162, 8145, 3

+∞

74.8

C08CA02, ,

ATC

felodipine; oral

+∞

73.7

C08CA13, ,

ATC

lercanidipine; oral

+∞

73.7

R21, ,

ICD-O-3

+∞

73.7

G04CA52, ,

ATC

tamsulosin and dutasteride; systemic

+∞

73.7

Z000, ,

ICD-10 Finland

General medical examination

+∞

73.7

A02BX02, ,

ATC

sucralfate; oral

+∞

72.7

R55, ,

ICD-10 Finland

Syncope and collapse

+∞

72.7

SGB10, ,

ICD-O-3

+∞

72.7

P20, ,

ICD-O-3

+∞

72.7

R074, ,

ICD-O-3

+∞

72.7

N03AX12, ,

ATC

[U] gabapentin; oral

+∞

72.7

LC2BE, ,

ICD-O-3

+∞

72.7

C786, ,

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

72.7

A10AE04, ,

ATC

insulin glargine; parenteral

+∞

72.7

I2081, ,

ICD-10 Finland

Other angina pectoris stenosed coronary artery

+∞

71.6

PH2AE, ,

ICD-O-3

+∞

71.6

R01AD01, ,

ATC

beclometasone; nasal

+∞

71.6

M255, ,

ICD-O-3

+∞

71.6

R31, ,

ICD-10 Finland

Unspecified haematuria

+∞

70.6

JCA55, ,

ICD-O-3

+∞

70.6

JKA21, ,

ICD-O-3

+∞

70.6

WX600, ,

ICD-O-3

+∞

70.6

SPAT1053, ,

ICD-O-3

+∞

70.6

N06AB03, ,

ATC

fluoxetine; oral

+∞

70.6

N05BA06, ,

ATC

lorazepam; systemic, sublingual

+∞

70.6

SFA00, ,

ICD-O-3

+∞

69.5

K0382, ,

ICD-O-3

+∞

69.5

504, ,

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

+∞

69.5

C61, ,

ICD-10 Finland

Malignant neoplasm of prostate

+∞

69.5

L13, ,

ICD-O-3

+∞

69.5

Z011, ,

ICD-10 Finland

Examination of ears and hearing

+∞

69.5

WW200, ,

ICD-O-3

+∞

69.5

UJF45, ,

ICD-O-3

+∞

69.5

U02, ,

ICD-O-3

+∞

69.5

Y83, ,

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

+∞

69.5

R06AX13, ,

ATC

loratadine; oral

+∞

68.4

K920, ,

ICD-10 Finland

Haematemesis

+∞

68.4

D07XC01, ,

ATC

betamethasone; topical

+∞

68.4

N17, ,

ICD-O-3

+∞

68.4

R2130, ,

ICD-O-3

+∞

68.4

K210, ,

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

+∞

68.4

I251, ,

ICD-O-3

+∞

67.4

R103, ,

ICD-10 Finland

Pain localized to other parts of lower abdomen

+∞

67.4

D07CC01, ,

ATC

betamethasone and antibiotics; topical

+∞

67.4

L12, ,

ICD-O-3

+∞

67.4

J01MA14, ,

ATC

moxifloxacin; systemic

+∞

66.3

H258, ,

ICD-10 Finland

Other senile cataract

+∞

66.3

A46, ,

ICD-10 Finland

Erysipelas

+∞

66.3

N06AA09, ,

ATC

amitriptyline; systemic

+∞

66.3

114, ,

Kela drug reimbursment

Glaucoma

+∞

66.3

C1604, ,

ICD-10 Finland

Malignant tumor of cardiac intestinal carcinoma

+∞

66.3

WX892, ,

ICD-O-3

+∞

66.3

WF049, ,

ICD-O-3

+∞

66.3

B01AF02, ,

ATC

apixaban; oral

+∞

66.3

H02, ,

ICD-O-3

+∞

66.3

A10BB12, ,

ATC

glimepiride; oral

+∞

65.2

M751, ,

ICD-10 Finland

Rotator cuff syndrome

+∞

65.2

XCW99, ,

ICD-O-3

+∞

65.2

N390, ,

ICD-10 Finland

Urinary tract infection, site not specified

+∞

65.2

K0365, ,

ICD-O-3

+∞

65.2

J01MA01, ,

ATC

ofloxacin; systemic

+∞

65.2

J209, ,

ICD-O-3

+∞

64.2

Z3229, ,

ICD-O-3

+∞

64.2

R03AK03, ,

ATC

[U] fenoterol and ipratropium bromide

+∞

64.2

B01AF01, ,

ATC

rivaroxaban; oral

+∞

64.2

QAE10, ,

ICD-O-3

+∞

64.2

A10AC01, ,

ATC

insulin (human); parenteral

+∞

64.2

R06AX22, ,

ATC

ebastine; oral

+∞

63.1

I269, ,

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

+∞

63.1

C619, 8140, 3

+∞

63.1

R103, ,

ICD-O-3

+∞

63.1

R01AD58, ,

ATC

fluticasone, combinations; nasal

+∞

63.1

A99, ,

ICD-O-3

+∞

63.1

I639, ,

ICD-10 Finland

Cerebral infarction, unspecified

+∞

63.1

K259, ,

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

+∞

63.1

UJF30, ,

ICD-O-3

+∞

63.1

D01AE16, ,

ATC

amorolfine; topical

+∞

63.1

-44, ,

ICD-O-3

+∞

63.1

FM1DE, ,

ICD-O-3

+∞

63.1

N40, ,

ICD-O-3

+∞

63.1

SGA01, ,

ICD-O-3

+∞

63.1

SGA02, ,

ICD-O-3

+∞

62.0

I252, ,

ICD-10 Finland

Old myocardial infarction

+∞

62.0

R18, ,

ICD-10 Finland

Ascites

+∞

62.0

FB1BD, ,

ICD-O-3

+∞

62.0

D74, ,

ICD-O-3

+∞

62.0

D649, ,

ICD-O-3

+∞

62.0

JDC20, ,

ICD-O-3

+∞

62.0

R33, ,

ICD-10 Finland

Retention of urine

+∞

62.0

81, ,

ICD-O-3

+∞

62.0

213, ,

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

+∞

62.0

M01AG02, ,

ATC

tolfenamic acid; oral, rectal

+∞

61.0

TQW40, ,

ICD-O-3

+∞

61.0

J05AB11, ,

ATC

valaciclovir; oral

+∞

61.0

-50, ,

ICD-O-3

+∞

61.0

C03AA03, ,

ATC

hydrochlorothiazide; oral

+∞

61.0

A10BH01, ,

ATC

sitagliptin; oral

+∞

61.0

TKC20, ,

ICD-O-3

+∞

61.0

Z017, ,

ICD-O-3

+∞

61.0

R02, ,

ICD-O-3

+∞

61.0

R238, ,

ICD-O-3

+∞

61.0

A10BB01, ,

ATC

glibenclamide; oral

+∞

61.0

A02BD07, ,

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

+∞

59.9

C160, 8145, 3

+∞

59.9

XJD02, ,

ICD-O-3

+∞

59.9

L01, ,

ICD-O-3

+∞

59.9

TQX10, ,

ICD-O-3

+∞

59.9

SPAT1304, ,

ICD-O-3

+∞

59.9

M161, ,

ICD-10 Finland

Other primary coxarthrosis

+∞

59.9

E780, ,

ICD-O-3

+∞

59.9

KH1AE, ,

ICD-O-3

+∞

58.9

ZXD20, ,

ICD-O-3

+∞

58.9

C10AA04, ,

ATC

fluvastatin; oral

+∞

58.9

D377, ,

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

+∞

58.9

R03AC03, ,

ATC

terbutaline; inhalant

+∞

58.9

L309, ,

ICD-10 Finland

Dermatitis, unspecified

+∞

58.9

SPAT1292, ,

ICD-O-3

+∞

58.9

202, ,

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

+∞

58.9

KE1BE, ,

ICD-O-3

+∞

58.9

A07AA02, ,

ATC

nystatin; oral

+∞

57.8

N06AX16, ,

ATC

venlafaxine; oral

+∞

57.8

B01AC07, ,

ATC

dipyridamole; systemic

+∞

57.8

M480, ,

ICD-10 Finland

Spinal stenosis

+∞

57.8

WD115, ,

ICD-O-3

+∞

57.8

Z718, ,

ICD-O-3

+∞

57.8

SPAT1217, ,

ICD-O-3

+∞

57.8

WB123, ,

ICD-O-3

+∞

57.8

JN5DR, ,

ICD-O-3

+∞

57.8

G04CB02, ,

ATC

dutasteride; oral

+∞

56.7

XF402, ,

ICD-O-3

+∞

56.7

M05BX04, ,

ATC

denosumab; parenteral

+∞

56.7

E000002, ,

ATC

+∞

56.7

JF1AB, ,

ICD-O-3

+∞

56.7

D06AX01, ,

ATC

fusidic acid; topical

+∞

56.7

K041, ,

ICD-O-3

+∞

55.7

C159, ,

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

+∞

55.7

C09DA01, ,

ATC

losartan and diuretics; oral

+∞

55.7

W19, ,

ICD-10 Finland

Unspecified fall

+∞

55.7

WX100, ,

ICD-O-3

+∞

55.7

J069, ,

ICD-10 Finland

Acute upper respiratory infection, unspecified

+∞

55.7

R83, ,

ICD-O-3

+∞

55.7

M01AB01, ,

ATC

indometacin; systemic, rectal

+∞

55.7

K449, ,

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

+∞

55.7

WD405, ,

ICD-O-3

+∞

55.7

C1601, ,

ICD-10 Finland

Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma

+∞

55.7

50099, ,

ICD-8 Finland

Hypertrophy of tonsils and adenoids

+∞

54.6

K30, ,

ICD-O-3

+∞

54.6

C1634, ,

ICD-10 Finland

Malignant tumor of the antrum ventriculi intestinal carcinoma

+∞

54.6

J01MA06, ,

ATC

norfloxacin; oral

+∞

54.6

G560, ,

ICD-10 Finland

Carpal tunnel syndrome

+∞

54.6

K081, ,

ICD-O-3

+∞

54.6

H264, ,

ICD-10 Finland

After-cataract

+∞

53.6

I350, ,

ICD-10 Finland

Aortic (valve) stenosis

+∞

53.6

C07AB03, ,

ATC

atenolol; systemic

+∞

53.6

D01AC02, ,

ATC

miconazole; topical

+∞

53.6

D11, ,

ICD-O-3

+∞

53.6

C163, 8145, 3

+∞

53.6

R03DC03, ,

ATC

montelukast; oral

+∞

53.6

N05BA12, ,

ATC

alprazolam; oral

+∞

53.6

K86, ,

ICD-O-3

+∞

53.6

S01GX01, ,

ATC

cromoglicic acid; ophthalmic

+∞

53.6

J01AA04, ,

ATC

lymecycline; systemic

+∞

52.5

D07AB08, ,

ATC

desonide; topical

+∞

52.5

C08CA05, ,

ATC

nifedipine; systemic

+∞

52.5

E7801, ,

ICD-O-3

+∞

52.5

G03FA01, ,

ATC

norethisterone and estrogen; systemic

+∞

52.5

N05AD01, ,

ATC

haloperidol; systemic

+∞

52.5

UJC12, ,

ICD-O-3

+∞

52.5

ZXM10, ,

ICD-O-3

+∞

52.5

WB103, ,

ICD-O-3

+∞

52.5

NGD05, ,

ICD-O-3

+∞

52.5

JA3AT, ,

ICD-O-3

+∞

52.5

WX872, ,

ICD-O-3

+∞

52.5

201, ,

Kela drug reimbursment

Chronic cardiac insufficiency

+∞

52.5

J010, ,

ICD-O-3

+∞

52.5

X58, ,

ICD-10 Finland

Exposure to other specified factors

+∞

52.5

C1624, ,

ICD-10 Finland

Malignant tumor of the corpus ventriculi intestinal carcinoma

+∞

51.4

Z0389, ,

ICD-10 Finland

Observation for other suspected diseases and conditions

+∞

51.4

K250, ,

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

+∞

51.4

M54, ,

ICD-O-3

+∞

51.4

XCK10, ,

ICD-O-3

+∞

51.4

J01FA01, ,

ATC

erythromycin; systemic

+∞

51.4

M05BA04, ,

ATC

alendronic acid; oral

+∞

51.4

D126, ,

ICD-10 Finland

Benign neoplasm: Colon, unspecified

+∞

51.4

E118, ,

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

+∞

51.4

WX000, ,

ICD-O-3

+∞

51.4

XF603, ,

ICD-O-3

+∞

51.4

Z315, ,

ICD-10 Finland

Genetic counselling

+∞

50.4

ZXE03, ,

ICD-O-3

+∞

50.4

C09CA03, ,

ATC

valsartan; oral

+∞

50.4

D07BB04, ,

ATC

hydrocortisone butyrate and antiseptics; topical

+∞

50.4

A01AB09, ,

ATC

miconazole; local oral

+∞

50.4

A10AB05, ,

ATC

insulin aspart; parenteral

+∞

50.4

QBE10, ,

ICD-O-3

+∞

50.4

TFP20, ,

ICD-O-3

+∞

50.4

C787, ,

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

50.4

C163, 8140, 3

+∞

49.3

D500, ,

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

+∞

49.3

L82, ,

ICD-O-3

+∞

49.3

XJH00, ,

ICD-O-3

+∞

49.3

K5909, ,

ICD-10 Finland

Constipation, unspecified

+∞

49.3

C09BA02, ,

ATC

enalapril and diuretics; systemic

+∞

49.3

M232, ,

ICD-10 Finland

Derangement of meniscus due to old tear or injury

+∞

49.3

6322, ,

ICD-O-3

+∞

49.3

ZXD30, ,

ICD-O-3

+∞

49.3

SPAT1283, ,

ICD-O-3

+∞

49.3

XF404, ,

ICD-O-3

+∞

49.3

N133, ,

ICD-10 Finland

Other and unspecified hydronephrosis

+∞

49.3

K222, ,

ICD-10 Finland

Oesophageal obstruction

+∞

48.3

JD1EE, ,

ICD-O-3

+∞

48.3

SGC00, ,

ICD-O-3

+∞

48.3

Z2446, ,

ICD-O-3

+∞

48.3

M179, ,

ICD-O-3

+∞

48.3

SDE04, ,

ICD-O-3

+∞

48.3

C07AG02, ,

ATC

carvedilol; oral

+∞

48.3

L309, ,

ICD-O-3

+∞

48.3

A01, ,

ICD-O-3

+∞

48.3

A06AH03, ,

ATC

naloxegol; oral

+∞

48.3

D01AE15, ,

ATC

terbinafine; topical

+∞

48.3

S82, ,

ICD-O-3

+∞

48.3

R03DA04, ,

ATC

theophylline; systemic, rectal

+∞

48.3

E039, ,

ICD-10 Finland

Hypothyroidism, unspecified

+∞

48.3

G459, ,

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

+∞

48.3

178, ,

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

48.3

SPAT1043, ,

ICD-O-3

+∞

48.3

A50, ,

ICD-O-3

+∞

47.2

H01, ,

ICD-O-3

+∞

47.2

H29, ,

ICD-O-3

+∞

47.2

A03CA02, ,

ATC

clidinium and psycholeptics; oral

+∞

47.2

SPAT1083, ,

ICD-O-3

+∞

47.2

A44, ,

ICD-O-3

+∞

47.2

Z004, ,

ICD-10 Finland

General psychiatric examination, not elsewhere classified

+∞

47.2

C08DB01, ,

ATC

diltiazem; oral

+∞

47.2

XF600, ,

ICD-O-3

+∞

47.2

SAD01, ,

ICD-O-3

+∞

47.2

I2099, ,

ICD-10 Finland

Angina pectoris, unspecified

+∞

47.2

SPAT1144, ,

ICD-O-3

+∞

47.2

A09AA02, ,

ATC

multienzymes (lipase, protease etc.); oral

+∞

47.2

M511, ,

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

+∞

47.2

I500, ,

ICD-10 Finland

Congestive heart failure

+∞

47.2

ZX012, ,

ICD-O-3

+∞

47.2

K78, ,

ICD-O-3

+∞

47.2

A02BA03, ,

ATC

famotidine; systemic

+∞

46.2

S01ED51, ,

ATC

timolol, combinations; ophthalmic

+∞

46.2

D06, ,

ICD-O-3

+∞

46.2

KED22, ,

ICD-O-3

+∞

46.2

NA3AA, ,

ICD-O-3

+∞

46.2

ZY020, ,

ICD-O-3

+∞

46.2

C10AA03, ,

ATC

pravastatin; oral

+∞

46.2

F510, ,

ICD-O-3

+∞

46.2

M02AA15, ,

ATC

diclofenac; topical

+∞

46.2

SPAT1252, ,

ICD-O-3

+∞

46.2

SPAT1211, ,

ICD-O-3

+∞

46.2

R06AE09, ,

ATC

levocetirizine; oral

+∞

46.2

D509, ,

ICD-O-3

+∞

46.2

M01AB55, ,

ATC

diclofenac, combinations; oral

+∞

46.2

S010, ,

ICD-10 Finland

Open wound of scalp

+∞

46.2

JDC10, ,

ICD-O-3

+∞

46.2

K02, ,

ICD-O-3

+∞

46.2

B03BA02, ,

ATC

cyanocobalamin tannin complex; parenteral

+∞

45.1

JN3CD, ,

ICD-O-3

+∞

45.1

J01DA08, ,

ATC

[U] cefaclor

+∞

45.1

R600, ,

ICD-O-3

+∞

45.1

J209, ,

ICD-10 Finland

Acute bronchitis, unspecified

+∞

45.1

N07CA01, ,

ATC

betahistine; oral

+∞

45.1

DFF00, ,

ICD-O-3

+∞

45.1

N06AB06, ,

ATC

sertraline; oral

+∞

45.1

M544, ,

ICD-O-3

+∞

45.1

N02AC04, ,

ATC

dextropropoxyphene; oral

+∞

45.1

R509, ,

ICD-O-3

+∞

45.1

C10AX09, ,

ATC

ezetimibe; oral

+∞

45.1

SPAT1281, ,

ICD-O-3

+∞

45.1

Z000, ,

ICD-O-3

+∞

45.1

N06AX21, ,

ATC

duloxetine; oral

+∞

45.1

C03EB01, ,

ATC

furosemide and potassium-sparing agents; systemic

+∞

44.0

A01AB04, ,

ATC

amphotericin B; local oral

+∞

44.0

L01BC53, ,

ATC

tegafur, combinations; systemic

+∞

44.0

ZXE11, ,

ICD-O-3

+∞

44.0

JFA15, ,

ICD-O-3

+∞

44.0

S04, ,

ICD-O-3

+∞

44.0

HMAK, ,

ICD-O-3

+∞

44.0

NE1AA, ,

ICD-O-3

+∞

44.0

M170, ,

ICD-10 Finland

Primary gonarthrosis, bilateral

+∞

44.0

WX105, ,

ICD-O-3

+∞

44.0

R11, ,

ICD-O-3

+∞

44.0

R12, ,

ICD-O-3

+∞

44.0

A02BC04, ,

ATC

rabeprazole; oral

+∞

44.0

S15, ,

ICD-O-3

+∞

44.0

ZYC01, ,

ICD-O-3

+∞

44.0

111, ,

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

43.0

G04BD12, ,

ATC

mirabegron; oral

+∞

43.0

N179, ,

ICD-10 Finland

Acute renal failure, unspecified

+∞

43.0

N300, ,

ICD-O-3

+∞

43.0

C4431, ,

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

+∞

43.0

B82, ,

ICD-O-3

+∞

43.0

Z508, ,

ICD-10 Finland

Care involving use of other rehabilitation procedures

+∞

43.0

R298, ,

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

+∞

43.0

XFP20, ,

ICD-O-3

+∞

43.0

R748, ,

ICD-10 Finland

Abnormal levels of other serum enzymes

+∞

43.0

Z511, ,

ICD-10 Finland

Chemotherapy session for neoplasm

+∞

41.9

A07DA03, ,

ATC

loperamide; oral

+∞

41.9

K020, ,

ICD-O-3

+∞

41.9

R5180, ,

ICD-10 Finland

Headache

+∞

41.9

D01AC03, ,

ATC

econazole; topical

+∞

41.9

R568, ,

ICD-10 Finland

Other and unspecified convulsions

+∞

41.9

R01BA51, ,

ATC

phenylpropanolamine, combinations; oral

+∞

41.9

NG1AA, ,

ICD-O-3

+∞

41.9

EB1CA, ,

ICD-O-3

+∞

41.9

C1621, ,

ICD-10 Finland

Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma

+∞

41.9

C1623, ,

ICD-O-3

+∞

41.9

R418, ,

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

+∞

41.9

R05DA01, ,

ATC

ethylmorphine; oral

+∞

41.9

L02, ,

ICD-O-3

+∞

41.9

L570, ,

ICD-10 Finland

Actinic keratosis

+∞

40.9

R13, ,

ICD-O-3

+∞

40.9

WVA20, ,

ICD-O-3

+∞

40.9

AA1CG, ,

ICD-O-3

+∞

40.9

NGB20, ,

ICD-O-3

+∞

40.9

RD210, ,

ICD-O-3

+∞

40.9

N04BC05, ,

ATC

pramipexole; oral

+∞

40.9

S0251, ,

ICD-O-3

+∞

40.9

CK2X4, ,

ICD-O-3

+∞

40.9

I250, ,

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

+∞

40.9

S060, ,

ICD-10 Finland

Concussion

+∞

40.9

Z712, ,

ICD-10 Finland

Person consulting for explanation of investigation findings

+∞

40.9

U071, ,

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

+∞

40.9

L29, ,

ICD-O-3

+∞

40.9

SPAT1360, ,

ICD-O-3

+∞

40.9

U07, ,

ICD-O-3

+∞

40.9

KBV02, ,

ICD-O-3

+∞

39.8

45499, ,

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

+∞

39.8

I693, ,

ICD-10 Finland

Sequelae of cerebral infarction

+∞

39.8

WX725, ,

ICD-O-3

+∞

39.8

SGA04, ,

ICD-O-3

+∞

39.8

WF004, ,

ICD-O-3

+∞

39.8

TPH90, ,

ICD-O-3

+∞

39.8

M255, ,

ICD-10 Finland

Pain in joint

+∞

39.8

XPX99, ,

ICD-O-3

+∞

39.8

ZXE04, ,

ICD-O-3

+∞

39.8

D06BX01, ,

ATC

metronidazole; topical

+∞

39.8

S525, ,

ICD-10 Finland

Fracture of lower end of radius

+∞

39.8

K800, ,

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

+∞

39.8

K0530, ,

ICD-O-3

+∞

39.8

SPAT1229, ,

ICD-O-3

+∞

39.8

D07BA04, ,

ATC

hydrocortisone and antiseptics; topical

+∞

38.8

Z080, ,

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

+∞

38.8

N06CA01, ,

ATC

amitriptyline and psycholeptics; systemic

+∞

38.8

JDA55, ,

ICD-O-3

+∞

38.8

SCA02, ,

ICD-O-3

+∞

38.8

SPAT1240, ,

ICD-O-3

+∞

38.8

WD415, ,

ICD-O-3

+∞

38.8

I2149, ,

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

+∞

38.8

TPH30, ,

ICD-O-3

+∞

38.8

CJB10, ,

ICD-O-3

+∞

38.8

OAB73, ,

ICD-O-3

+∞

38.8

M01AC02, ,

ATC

tenoxicam; systemic, rectal

+∞

38.8

K0510, ,

ICD-O-3

+∞

38.8

F03, ,

ICD-O-3

+∞

37.7

GD1BD, ,

ICD-O-3

+∞

37.7

J90, ,

ICD-10 Finland

Pleural effusion, not elsewhere classified

+∞

37.7

SPAT1100, ,

ICD-O-3

+∞

37.7

H250, ,

ICD-10 Finland

Senile incipient cataract

+∞

37.7

55099, ,

ICD-8 Finland

Inguinal hernia without mention of obstruction

+∞

37.7

116, ,

Kela drug reimbursment

Prostate cancer

+∞

37.7

WF002, ,

ICD-O-3

+∞

37.7

SPAT1137, ,

ICD-O-3

+∞

37.7

EBA10, ,

ICD-O-3

+∞

37.7

E785, ,

ICD-10 Finland

Hyperlipidaemia, unspecified

+∞

37.7

FN1BC, ,

ICD-O-3

+∞

37.7

FN1AT, ,

ICD-O-3

+∞

37.7

T810, ,

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

+∞

37.7

ZXE05, ,

ICD-O-3

+∞

37.7

NF1AA, ,

ICD-O-3

+∞

37.7

6500B, ,

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

+∞

37.7

N05BB01, ,

ATC

hydroxyzine; systemic

+∞

36.7

TJD00, ,

ICD-O-3

+∞

36.7

B01AC06, ,

ATC

acetylsalicylic acid; oral

+∞

36.7

R01AD05, ,

ATC

budesonide; nasal

+∞

36.7

A419, ,

ICD-10 Finland

Sepsis, unspecified

+∞

36.7

SPAT1245, ,

ICD-O-3

+∞

36.7

G03BA03, ,

ATC

testosterone; systemic, rectal, sublingual, transdermal

+∞

36.7

JCC10, ,

ICD-O-3

+∞

36.7

ZXE40, ,

ICD-O-3

+∞

36.7

GD1AD, ,

ICD-O-3

+∞

36.7

Z016, ,

ICD-O-3

+∞

36.7

EB1VA, ,

ICD-O-3

+∞

36.7

L11, ,

ICD-O-3

+∞

36.7

E883A, ,

ICD-9 Finland

Fall into hole or other opening in surface

+∞

36.7

J01FA15, ,

ATC

telithromycin; oral

+∞

36.7

G03AC03, ,

ATC

levonorgestrel; oral, implant

+∞

36.7

K0531, ,

ICD-O-3

+∞

36.7

C162, 8140, 3

+∞

36.7

M706, ,

ICD-O-3

+∞

35.6

SPAT1324, ,

ICD-O-3

+∞

35.6

N300, ,

ICD-10 Finland

Acute cystitis

+∞

35.6

D02, ,

ICD-O-3

+∞

35.6

C09DA06, ,

ATC

candesartan and diuretics; oral

+∞

35.6

W00, ,

ICD-10 Finland

Fall on same level involving ice and snow

+∞

35.6

A10BX01, ,

ATC

guar gum; oral

+∞

35.6

I499, ,

ICD-10 Finland

Cardiac arrhythmia, unspecified

+∞

35.6

EBA15, ,

ICD-O-3

+∞

35.6

ND2AA, ,

ICD-O-3

+∞

35.6

Z461, ,

ICD-10 Finland

Fitting and adjustment of hearing aid

+∞

35.6

J45, ,

ICD-O-3

+∞

35.6

K219, ,

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

+∞

35.6

K565, ,

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

+∞

35.6

B01AC30, ,

ATC

platelet aggregation inhibitors excl. heparin - combinations

+∞

35.6

KE1AT, ,

ICD-O-3

+∞

35.6

I489, ,

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

+∞

35.6

R03BB01, ,

ATC

ipratropium bromide; inhalant

+∞

35.6

M09AA72, ,

ATC

quinine, combinations with psycholeptics; systemic

+∞

35.6

L14, ,

ICD-O-3

+∞

35.6

TQW99, ,

ICD-O-3

+∞

34.6

G03DA02, ,

ATC

medroxyprogesterone; systemic

+∞

34.6

N06DX01, ,

ATC

memantine; oral

+∞

34.6

FN1YT, ,

ICD-O-3

+∞

34.6

SPAT1104, ,

ICD-O-3

+∞

34.6

Z258, ,

ICD-O-3

+∞

34.6

C02EA02, ,

ATC

+∞

34.6

N02AA01, ,

ATC

morphine; systemic, rectal

+∞

34.6

G03DC02, ,

ATC

norethisterone; oral

+∞

34.6

OAB43, ,

ICD-O-3

+∞

34.6

D128, ,

ICD-10 Finland

Benign neoplasm: Rectum

+∞

34.6

SPAT1058, ,

ICD-O-3

+∞

34.6

J01EE01, ,

ATC

sulfamethoxazole and trimethoprim; systemic

+∞

34.6

J459, ,

ICD-O-3

+∞

34.6

C165, ,

ICD-10 Finland

Malignant neoplasm: Lesser curvature of stomach, unspecified

+∞

34.6

N06AA12, ,

ATC

doxepin; systemic

+∞

34.6

E039, ,

ICD-O-3

+∞

34.6

N03AF01, ,

ATC

carbamazepine; oral, rectal

+∞

34.6

G03FB06, ,

ATC

medroxyprogesterone and estrogen; systemic

+∞

34.6

L04AX03, ,

ATC

methotrexate; systemic

+∞

34.6

M09AX01, ,

ATC

hyaluronic acid; parenteral

+∞

34.6

H3530, ,

ICD-10 Finland

Kuhnt-Junius degeneration

+∞

34.6

M791, ,

ICD-O-3

+∞

33.5

SFC92, ,

ICD-O-3

+∞

33.5

SPAT1285, ,

ICD-O-3

+∞

33.5

F101, ,

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

+∞

33.5

N201, ,

ICD-10 Finland

Calculus of ureter

+∞

33.5

N05AH03, ,

ATC

olanzapine; systemic

+∞

33.5

-31, ,

ICD-O-3

+∞

33.5

AA1BD, ,

ICD-O-3

+∞

33.5

A415, ,

ICD-10 Finland

Sepsis due to other Gram-negative organisms

+∞

33.5

NH3AA, ,

ICD-O-3

+∞

33.5

M17, ,

ICD-O-3

+∞

33.5

R03AC12, ,

ATC

salmeterol; inhalant

+∞

33.5

R5140, ,

ICD-O-3

+∞

33.5

104, ,

Kela drug reimbursment

Thyroid insufficiency

+∞

33.5

JMA10, ,

ICD-O-3

+∞

33.5

R01AD11, ,

ATC

triamcinolone; nasal

+∞

33.5

LX1AE, ,

ICD-O-3

+∞

33.5

NA3BG, ,

ICD-O-3

+∞

33.5

FNA01, ,

ICD-O-3

+∞

33.5

G01AA10, ,

ATC

clindamycin; vaginal

+∞

33.5

GA4YT, ,

ICD-O-3

+∞

33.5

I842, ,

ICD-10 Finland

Internal hemorrhoids without complication

+∞

33.5

112, ,

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

33.5

K80, ,

ICD-O-3

+∞

33.5

WX720, ,

ICD-O-3

+∞

33.5

R03BC03, ,

ATC

nedocromil; inhalant

+∞

33.5

NFB30, ,

ICD-O-3

+∞

33.5

E117, ,

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

+∞

33.5

I839, ,

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

+∞

33.5

Z015, ,

ICD-10 Finland

Diagnostic skin and sensitization tests

+∞

33.5

A07EC01, ,

ATC

sulfasalazine; oral, rectal

+∞

33.5

P03, ,

ICD-O-3

+∞

33.5

R073, ,

ICD-10 Finland

Other chest pain

+∞

32.4

EBA30, ,

ICD-O-3

+∞

32.4

K567, ,

ICD-10 Finland

Ileus, unspecified

+∞

32.4

Z950, ,

ICD-10 Finland

Presence of electronic cardiac devices

+∞

32.4

N06AB05, ,

ATC

paroxetine; oral

+∞

32.4

M170, ,

ICD-O-3

+∞

32.4

4549X, ,

ICD-9 Finland

Varicose veins of lower extremities, Without mention of ulcer or inflammation

+∞

32.4

P01, ,

ICD-O-3

+∞

32.4

A11, ,

ICD-O-3

+∞

32.4

I2141, ,

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

+∞

32.4

G03FB05, ,

ATC

norethisterone and estrogen; systemic

+∞

32.4

SGA03, ,

ICD-O-3

+∞

32.4

K253, ,

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

+∞

32.4

6123, ,

ICD-O-3

+∞

32.4

WYA30, ,

ICD-O-3

+∞

32.4

J20, ,

ICD-O-3

+∞

32.4

A79, ,

ICD-O-3

+∞

32.4

RD211, ,

ICD-O-3

+∞

32.4

E86, ,

ICD-10 Finland

Volume depletion

+∞

32.4

R529, ,

ICD-O-3

+∞

32.4

F329, ,

ICD-10 Finland

Depressive episode, unspecified

+∞

31.4

F29, ,

ICD-O-3

+∞

31.4

D09, ,

ICD-O-3

+∞

31.4

A10BD07, ,

ATC

metformin and sitagliptin; systemic

+∞

31.4

L16, ,

ICD-O-3

+∞

31.4

FN2BA, ,

ICD-O-3

+∞

31.4

G03CA04, ,

ATC

estriol; systemic, vaginal

+∞

31.4

WYA10, ,

ICD-O-3

+∞

31.4

J449, ,

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

+∞

31.4

K044, ,

ICD-O-3

+∞

31.4

8113, ,

ICD-O-3

+∞

31.4

A10BK03, ,

ATC

empagliflozin; oral

+∞

31.4

R065, ,

ICD-10 Finland

Mouth breathing

+∞

31.4

SPAT1081, ,

ICD-O-3

+∞

31.4

K083, ,

ICD-O-3

+∞

31.4

SPAT1212, ,

ICD-O-3

+∞

31.4

T91, ,

ICD-O-3

+∞

31.4

C16, ,

ICD-O-3

Stomach

+∞

31.4

E000006, ,

ATC

+∞

31.4

K257, ,

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

+∞

31.4

N03AE01, ,

ATC

clonazepam; systemic

+∞

31.4

I872, ,

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

+∞

31.4

S826, ,

ICD-10 Finland

Fracture of lateral malleolus

+∞

31.4

K04, ,

ICD-O-3

+∞

31.4

133, ,

Kela drug reimbursment

Severe chronic pancreatic insufficiency

+∞

30.3

OAA65, ,

ICD-O-3

+∞

30.3

SXB00, ,

ICD-O-3

+∞

30.3

LCA06, ,

ICD-O-3

+∞

30.3

Z951, ,

ICD-10 Finland

Presence of aortocoronary bypass graft

+∞

30.3

SGB30, ,

ICD-O-3

+∞

30.3

R29, ,

ICD-O-3

+∞

30.3

QBB10, ,

ICD-O-3

+∞

30.3

NB1AA, ,

ICD-O-3

+∞

30.3

C1631, ,

ICD-10 Finland

Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma

+∞

30.3

I351, ,

ICD-10 Finland

Aortic (valve) insufficiency

+∞

30.3

Z014, ,

ICD-10 Finland

Gynaecological examination (general)(routine)

+∞

30.3

ZXE06, ,

ICD-O-3

+∞

30.3

384, ,

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

30.3

K439, ,

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

+∞

30.3

H438, ,

ICD-10 Finland

Other disorders of vitreous body

+∞

30.3

N05AA02, ,

ATC

levomepromazine; systemic

+∞

30.3

M544, ,

ICD-10 Finland

Lumbago with sciatica

+∞

30.3

ZXE02, ,

ICD-O-3

+∞

30.3

D131, ,

ICD-10 Finland

Benign neoplasm: Stomach

+∞

30.3

AA1BG, ,

ICD-O-3

+∞

30.3

C09AA03, ,

ATC

lisinopril; oral

+∞

30.3

N05AX08, ,

ATC

risperidone; systemic

+∞

30.3

R05, ,

ICD-10 Finland

Cough

+∞

30.3

G01AF01, ,

ATC

metronidazole; vaginal

+∞

30.3

C05AA01, ,

ATC

hydrocortisone; rectal, topical

+∞

30.3

JEA00, ,

ICD-O-3

+∞

30.3

A12BA01, ,

ATC

potassium chloride; oral

+∞

30.3

A10AE05, ,

ATC

insulin detemir; parenteral

+∞

30.3

WX882, ,

ICD-O-3

+∞

30.3

P01BA02, ,

ATC

hydroxychloroquine; oral

+∞

30.3

Z035, ,

ICD-10 Finland

Observation for other suspected cardiovascular diseases

+∞

30.3

S720, ,

ICD-10 Finland

Fracture of neck of femur

+∞

29.3

S01ED01, ,

ATC

timolol; ophthalmic

+∞

29.3

S06, ,

ICD-O-3

+∞

29.3

N390, ,

ICD-O-3

+∞

29.3

ACC51, ,

ICD-O-3

+∞

29.3

I509, ,

ICD-O-3

+∞

29.3

I2009, ,

ICD-10 Finland

Unstable angina

+∞

29.3

S01EE01, ,

ATC

latanoprost; ophthalmic

+∞

29.3

SPAT1295, ,

ICD-O-3

+∞

29.3

K805, ,

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

+∞

29.3

M160, ,

ICD-10 Finland

Primary coxarthrosis, bilateral

+∞

29.3

L03AA14, ,

ATC

lipegfilgrastim; parenteral

+∞

29.3

NBG15, ,

ICD-O-3

+∞

29.3

SPAT1130, ,

ICD-O-3

+∞

29.3

E871, ,

ICD-10 Finland

Hypo-osmolality and hyponatraemia

+∞

29.3

C1602, ,

ICD-10 Finland

Malignant tumor of cardiac early intestinal gastric carcinoma

+∞

29.3

I2000, ,

ICD-10 Finland

Unstable angina

+∞

29.3

M549, ,

ICD-10 Finland

Dorsalgia, unspecified

+∞

29.3

A09, ,

ICD-O-3

+∞

29.3

GAA10, ,

ICD-O-3

+∞

29.3

J448, ,

ICD-O-3

+∞

29.3

C10AA02, ,

ATC

lovastatin; oral

+∞

29.3

ND1AA, ,

ICD-O-3

+∞

29.3

S460, ,

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

+∞

29.3

I702, ,

ICD-O-3

+∞

29.3

-60, ,

ICD-O-3

+∞

29.3

K30, ,

ICD-10 Finland

Functional dyspepsia

+∞

29.3

R96, ,

ICD-O-3

+∞

29.3

GD5AD, ,

ICD-O-3

+∞

28.2

E118, ,

ICD-O-3

+∞

28.2

A46, ,

ICD-O-3

+∞

28.2

WX702, ,

ICD-O-3

+∞

28.2

O800, ,

ICD-10 Finland

Spontaneous vertex delivery

+∞

28.2

G473, ,

ICD-O-3

+∞

28.2

E876, ,

ICD-10 Finland

Hypokalaemia

+∞

28.2

G442, ,

ICD-O-3

+∞

28.2

G04BD04, ,

ATC

oxybutynin; oral, transdermal

+∞

28.2

R040, ,

ICD-10 Finland

Epistaxis

+∞

28.2

K22, ,

ICD-O-3

+∞

28.2

376, ,

Kela drug reimbursment

Cyanocobalamin

+∞

28.2

R634, ,

ICD-10 Finland

Abnormal weight loss

+∞

28.2

H0410, ,

ICD-10 Finland

Dry eye syndrome

+∞

28.2

R05DB20, ,

ATC

other cough suppressants - combinations

+∞

28.2

H023, ,

ICD-10 Finland

Blepharochalasis

+∞

28.2

C07AA07, ,

ATC

sotalol; systemic

+∞

28.2

L04, ,

ICD-O-3

+∞

28.2

K529, ,

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

+∞

28.2

NGF25, ,

ICD-O-3

+∞

28.2

A10BH05, ,

ATC

linagliptin; oral

+∞

28.2

D02AE01, ,

ATC

carbamide; topical

+∞

28.2

S01AA01, ,

ATC

chloramphenicol; ophthalmic

+∞

28.2

G03DB01, ,

ATC

dydrogesterone; oral

+∞

28.2

R600, ,

ICD-10 Finland

Localized oedema

+∞

28.2

R01BA01, ,

ATC

phenylpropanolamine; oral

+∞

28.2

C09CA07, ,

ATC

telmisartan; oral

+∞

27.2

Z988, ,

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

511

379

23.56

307.65

6.4

1.4

28.74

2.78

ug/l

3.32

478

292

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

298

145

27.44

307.65

5.8

1.7

598.81

48.45

u/ml

0.70

281

112

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

196

31.33

290.94

4.6

1.7

172.61

39.37

u/ml

1.60

183

(4035726) Immunohistochemistry procedure

227

167

16.71

251.94

1.7

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

328

580

7.53

188.70

3.3

1.9

0.20

0.19

g/l

0.54

319

515

(40768797) Stomach Pathology biopsy report

409

970

6.01

173.09

1.9

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

345

1129

3.94

90.87

3.6

2.5

0.81

0.83

mmol/l

2.66

331

1025

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

88.71

1.0

0.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

611

3249

2.89

67.51

10.6

3.7

32.17

35.02

g/l

27.03

594

2954

(3002256) Pathology report gross observation

178

471

4.29

61.26

1.6

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

632

3671

2.61

54.89

15.2

3.7

11.55

12.79

umol/l

1.46

619

3422

(3003458) Phosphate [Moles/volume] in Serum or Plasma

269

1018

3.15

53.49

4.2

4.8

0.98

1.02

mmol/l

1.52

261

912

(3044640) Blood type and Crossmatch panel - Blood

422

2128

2.56

47.76

3.9

2.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

445

2340

2.48

45.60

3.3

2.3

66.24

59.56

u/l

0.84

417

2142

(3014576) Chloride [Moles/volume] in Serum or Plasma

245

985

2.89

42.92

10.9

5.9

104.93

104.52

mmol/l

0.65

245

985

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

205

746

3.13

42.89

4.1

2.2

9.46

9.78

umol/l

0.06

186

647

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

175

616

3.17

38.52

4.9

2.1

37.54

31.34

u/l

1.37

160

497

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

531

3196

2.23

38.02

3.8

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

328

1640

2.40

36.15

3.5

2.1

—

(40768804) Tissue Pathology biopsy report

383

2050

2.31

36.04

2.9

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

268

1247

2.50

34.40

2.4

10.68

12.64

umol/l

4.10

253

1132

(3023368) Bacteria identified in Blood by Culture

412

2325

2.21

33.66

4.9

4.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

420

2404

2.18

32.97

6.7

2.0

2.31

2.34

mmol/l

6.40

403

1978

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

288

1437

2.34

31.32

7.1

2.2

2.46

2.44

mmol/l

2.93

279

1215

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

564

7618

0.49

30.69

4.1

5.3

2.43

2.58

mmol/l

3.78

506

6904

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

124

407

3.30

30.40

10.6

10.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

584

3887

2.03

29.73

15.6

5.9

4.10

4.48

e9/l

1.38

520

3339

(3000570) Elastase.pancreatic [Mass/mass] in Stool

194

4.30

29.51

1.7

1.4

241.58

286.17

ug/g

1.34

114

(3022217) INR in Platelet poor plasma by Coagulation assay

598

4045

2.00

28.75

13.9

19.7

1.26

1.43

inr

5.03

177

1118

(3004789) Transferrin [Mass/volume] in Serum or Plasma

238

1133

2.39

28.55

2.3

2.4

2.46

2.23

g/l

5.77

222

1029

(4281824) Cell count and differential, peritoneal fluid

10.59

28.10

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

552

7400

0.51

27.21

3.7

4.7

4.32

4.42

mmol/l

1.50

496

6746

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

224

1059

2.39

27.18

2.3

2.5

17.61

22.70

5.35

184

883

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

374

2182

2.06

26.83

5.0

2.6

44.64

34.63

u/l

1.33

368

2067

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

546

7321

0.51

26.49

3.6

4.7

1.47

1.40

mmol/l

2.93

482

6620

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

364

2114

2.06

26.36

2.6

2.2

3.28

3.01

mg/l

1.02

332

1759

(3020779) Urea [Moles/volume] in Serum or Plasma

168

705

2.62

26.26

4.0

6.1

7.92

11.49

mmol/l

7.21

157

656

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

541

7207

0.53

24.52

6.5

40.95

41.15

mmol/mol

0.17

489

6586

(3002173) Hemoglobin [Mass/volume] in Arterial blood

174

777

2.46

23.76

10.4

7.6

113.67

121.69

g/l

5.94

169

759

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

137

545

2.72

23.72

1.4

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

125

4.66

23.56

3.4

1.5

56.44

25.41

u/ml

1.22

119

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

541

7086

0.55

21.26

3.4

4.2

1.19

1.28

mmol/l

3.10

479

6352

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

276

3.25

21.10

2.0

2.8

0.34

0.36

u/ml

0.09

167

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

516

6836

0.55

20.91

4.2

4.3

1.93

2.21

mu/l

0.80

460

6099

(3016502) Oxygen saturation in Arterial blood

179

871

2.25

19.90

10.2

7.1

96.68

94.71

6.40

172

838

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

594

7505

0.57

19.36

4.2

4.9

6.07

6.12

mmol/l

0.35

536

6712

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

537

3831

1.76

18.97

9.3

5.5

1.19

1.21

mmol/l

6.90

451

3251

(3003396) Base excess in Arterial blood by calculation

189

963

2.15

18.68

9.7

6.8

1.08

1.24

mmol/l

0.18

158

742

(3027801) Oxygen [Partial pressure] in Arterial blood

186

969

2.10

17.27

10.0

6.8

13.12

11.10

kpa

6.10

178

921

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

186

969

2.10

17.27

10.0

6.8

5.18

5.06

kpa

0.98

178

921

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

487

3465

1.71

16.72

8.2

5.3

1.19

1.21

mmol/l

5.89

466

3067

(3000991) Gas panel - Venous blood

141

676

2.24

16.11

10.9

6.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

702

8308

0.60

14.97

45.7

20.8

119.12

135.72

g/l

128.68

684

8080

(3026361) Erythrocytes [#/volume] in Blood

702

8307

0.60

14.94

45.5

20.7

4.07

4.47

e12/l

68.32

672

7948

(3035941) MCH [Entitic mass]

702

8307

0.60

14.94

45.3

20.6

29.82

30.51

13.90

686

8084

(3024731) MCV [Entitic volume]

702

8305

0.60

14.89

45.4

20.6

90.96

91.66

2.82

686

8080

(3007461) Platelets [#/volume] in Blood

702

8304

0.60

14.87

45.5

20.7

262.07

237.49

e9/l

12.55

677

7984

(3009542) Hematocrit [Volume Fraction] of Blood

702

8302

0.60

14.82

46.7

20.7

36.24

40.00

54.73

632

7544

(3010813) Leukocytes [#/volume] in Blood

703

8308

0.60

14.75

45.4

20.7

7.40

6.89

e9/l

1.38

671

7954

(3018418) pH of Serum or Plasma

333

2217

1.71

14.09

4.9

3.1

7.39

7.40

0.44

373

(3003694) ABO and Rh group [Type] in Blood

271

1720

1.75

13.54

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

415

5443

0.63

12.46

3.6

3.5

14.76

15.02

pmol/l

1.07

374

4852

(3001122) Ferritin [Mass/volume] in Serum or Plasma

408

2966

1.58

11.76

3.4

2.7

80.71

143.62

ug/l

11.97

384

2686

(3042936) Bacteria identified in Isolate by Culture

187

1108

1.82

11.65

1.9

2.0

—

(40758558) Short blood count panel - Blood

256

1683

1.67

10.99

10.9

4.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

209

2.77

10.93

1.5

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

28.31

10.74

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

583

4661

1.51

10.54

8.0

4.5

6.64

6.91

mmol/l

3.35

566

4347

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

691

7981

0.66

10.06

19.8

9.0

29.67

25.73

u/l

0.70

671

7568

(3017181) Myelocytes/100 leukocytes in Blood

500

2.07

9.85

2.1

3.6

1.47

0.79

1.09

146

(3023103) Potassium [Moles/volume] in Serum or Plasma

699

8037

0.67

9.73

36.8

17.6

3.96

4.02

mmol/l

7.43

677

7743

(40761511) CBC panel - Blood by Automated count

669

7746

0.67

9.50

29.2

13.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

699

8019

0.67

9.40

36.7

17.5

138.80

139.75

mmol/l

16.34

679

7740

(3021440) Promyelocytes/100 leukocytes in Blood

474

2.02

8.68

2.2

3.7

0.07

0.06

0.03

120

(3002179) Metamyelocytes/100 leukocytes in Blood

454

2.04

8.63

2.1

3.6

1.11

0.64

0.56

126

(1761868) Lipid panel - Serum or Plasma

143

2269

0.58

8.62

2.7

3.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

225

3194

0.63

8.56

3.9

3.7

23.19

24.20

0.44

110

1552

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

676

5710

1.45

8.41

16.7

5.2

110.04

76.91

u/l

14.24

657

5232

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

297

3947

0.67

8.16

4.1

3.8

2.24

2.15

ug/l

0.20

264

3507

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

508

1.95

8.08

1.6

1.5

—

(3012516) Albumin [Mass/volume] in Urine

179

2646

0.62

8.04

2.9

3.2

425.49

206.51

mg/l

0.25

114

1728

(40768806) Pleura Pathology biopsy report

3.68

8.04

1.2

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

7.30

7.97

1.8

2.0

487.33

263.65

e6/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

104

577

1.88

7.92

4.7

3.2

1.21

1.22

mmol/l

0.43

487

(3020682) Albumin/Creatinine [Ratio] in Urine

196

2807

0.64

7.58

3.4

3.8

11.82

8.54

mg/mmol

0.35

126

1813

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1065

0.45

7.54

1.2

81.71

14.96

u/ml

0.43

399

(3021960) Folate [Moles/volume] in Serum or Plasma

285

2081

1.49

7.44

1.9

1.6

22.13

19.64

nmol/l

2.01

263

1749

(3026493) Urate [Moles/volume] in Serum or Plasma

136

2111

0.60

7.39

2.2

2.5

2968.82

8580.86

umol/l

1.23

119

1793

(3039000) Anion gap in Blood

181

2.49

7.16

7.0

8.6

10.85

11.45

mmol/l

0.45

166

(3018572) Chloride [Moles/volume] in Blood

181

2.49

7.16

7.0

8.6

106.13

105.92

mmol/l

0.12

166

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

7.58

6.91

1.9

1.8

726.00

94644.27

e6/l

—

(3047181) Lactate [Moles/volume] in Blood

274

2.18

6.90

6.1

7.0

1.66

1.34

mmol/l

0.53

245

(3044007) Cell count panel - Peritoneal fluid

8.32

6.83

2.1

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

138

2.66

6.76

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

156

1016

1.62

6.76

2.1

1.9

1.65

1.74

0.47

138

892

(3009508) Creatinine [Moles/volume] in Urine

192

2702

0.65

6.70

2.8

3.2

7.97

7.65

mmol/l

0.42

149

2252

(3025159) Blasts/100 leukocytes in Blood

453

1.90

6.67

2.3

3.7

0.00

0.03

1.08

104

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

147

2189

0.62

6.64

2.6

2.7

0.73

0.76

ug/l

0.19

110

1497

(3030905) Polymorphonuclear cells [#/volume] in Blood

112

2.82

6.51

2.4

2.9

4.43

4.81

e9/l

0.29

112

(3002582) Erythrocytes [#/volume] in Urine

312

2371

1.43

6.51

3.1

3.0

39.05

90.97

e6/l

1.09

246

1845

(3033799) Differential panel - Peritoneal fluid

7.45

6.42

1.9

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

126

1930

0.61

6.39

1.8

1.6

1.14

1.36

mmol/l

4.18

104

1599

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

610

6979

0.73

6.32

33.0

13.3

82.12

73.95

ml/min/173m2

18.61

542

5631

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

114

2.77

6.31

3.3

3.1

59.42

60.54

0.14

114

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

279

0.18

6.26

1.8

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

5.39

5.85

1.1

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

279

2116

1.42

5.80

3.0

2.9

1.07

0.43

e6/l

0.95

215

1630

(3019069) Monocytes/100 leukocytes in Blood

404

3268

1.37

5.70

4.2

5.6

9.44

8.86

1.94

387

3001

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

283

3613

0.71

5.67

2.4

2.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

478

5617

0.74

5.56

3.6

3.9

14.69

13.01

mm/h

1.53

434

5109

(3002030) Lymphocytes/100 leukocytes in Blood

409

3326

1.36

5.54

4.2

5.4

23.49

25.94

3.62

390

3069

(3006504) Eosinophils/100 leukocytes in Blood

401

3253

1.36

5.51

4.0

5.2

2.20

2.98

9.99

382

2988

(3023520) Reticulocytes [#/volume] in Blood

116

741

1.63

5.43

2.0

2.1

60.18

67.06

e9/l

1.27

575

(3022096) Basophils/100 leukocytes in Blood

388

3149

1.35

5.27

4.0

5.2

0.59

0.65

1.24

371

2883

(3008152) Bicarbonate [Moles/volume] in Arterial blood

578

1.68

5.11

7.4

7.6

25.22

24.34

mmol/l

1.34

554

(40760892) CBC W Ordered Manual Differential panel - Blood

394

3218

1.34

5.10

4.6

5.3

—

(3003338) MCHC [Mass/volume]

544

6234

0.76

5.08

41.5

18.9

327.16

332.35

g/l

30.29

534

6147

(3038177) Helicobacter pylori Ab [Presence] in Serum

2.99

5.00

1.4

1.3

—

(3019060) Gas panel - Arterial blood

590

1.67

4.98

5.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.51

4.90

1.1

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.52

4.78

1.0

1.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

118

782

1.57

4.76

2.1

2.5

217.29

239.21

u/l

1.96

110

721

(3007930) Methemoglobin/Hemoglobin.total in Blood

363

1.81

4.63

6.1

5.4

0.92

0.86

0.76

347

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

169

1217

1.46

4.59

3.1

2.8

2.32

1.89

e6/l

0.36

681

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

372

1.79

4.57

6.0

5.3

1.84

1.72

0.29

356

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1095

0.58

4.54

1.2

1.3

15.30

37.45

iu/ml

4.95

354

(3026782) Osmolality of Urine

213

1610

1.40

4.42

3.2

2.6

544.02

547.80

mosm/kgh2o

0.09

194

1356

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.85

4.40

1.3

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

207

2688

0.72

4.39

2.0

2.1

584.68

239.55

u/l

0.53

188

2499

(3002032) Base excess in Venous blood by calculation

125

857

1.51

4.33

3.5

3.0

2.46

2.02

mmol/l

0.58

100

695

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1020

0.58

4.33

3.5

4.8

34.27

32.42

0.65

667

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.81

4.30

1.3

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.81

4.30

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.77

4.20

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.77

4.20

1.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.77

4.20

1.3

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

884

0.56

4.13

1.2

1.3

413.33

537.55

titre

0.42

212

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

343

2829

1.30

3.96

3.0

—

(3018095) Leukocytes [#/volume] in Urine

328

2689

1.31

3.96

3.6

3.5

55.58

122.31

e6/l

2.17

253

1956

(3010421) pH of Blood

207

1.97

3.86

2.2

4.7

7.42

0.12

185

(36304419) Bacteria [Presence] in Urine

256

2035

1.33

3.83

3.0

2.9

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

223

0.27

3.78

1.5

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

419

3570

1.27

3.71

3.9

5.1

1.65

1.79

e9/l

2.05

355

3121

(40768800) Prostate Pathology biopsy report

3.03

3.69

1.1

—

(3022145) Colonoscopy Study observation

666

1.52

3.57

1.3

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

10.04

3.50

1.5

10099.33

1112.67

u/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

1.91

3.48

1.8

1.6

—

(3006315) Basophils [#/volume] in Blood

409

3502

1.26

3.41

3.9

5.0

0.04

e9/l

0.65

340

2994

(3001604) Monocytes [#/volume] in Blood

407

3489

1.26

3.35

3.9

5.0

0.67

0.62

e9/l

1.73

339

2980

(3018010) Neutrophils/100 leukocytes in Blood

387

3300

1.26

3.33

4.0

5.2

59.11

58.70

0.21

368

3048

(3000492) Spirometry study

594

1.52

3.32

1.4

1.5

—

(40768793) Breast Pathology biopsy report

3.66

3.29

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

718

0.57

3.27

1.4

1.5

—

(3012501) Base excess in Blood by calculation

170

1.97

3.26

2.4

5.1

3.15

2.83

mmol/l

0.30

106

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

240

1933

1.31

3.24

1.9

1.7

484.77

16964710.80

pmol/l

1.27

197

1568

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.46

3.22

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

467

0.48

3.13

2.0

2.5

—

13.05

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

694

7513

0.81

3.11

31.5

14.5

38.58

26.38

mg/l

15.58

643

5936

(3006653) Thiamine [Moles/volume] in Blood

3.20

3.06

1.2

1.3

115.15

135.38

nmol/l

1.44

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.46

3.05

1.0

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

208

1660

1.31

2.99

2.3

2.4

5.73

4.43

e6/l

1.47

192

1486

(3002385) Erythrocyte distribution width [Ratio]

568

6262

0.82

2.96

39.1

16.6

15.77

15.32

1.89

557

6085

(3052592) Norovirus Ag [Presence] in Stool

4.73

2.92

1.3

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

613

1.47

2.88

2.2

1.7

374.57

371.38

nmol/l

0.06

549

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

252

1.73

2.88

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.61

2.88

1.3

3.6

—

(40768795) Lymph node Pathology biopsy report

5.41

2.87

1.0

—

(3013115) Eosinophils [#/volume] in Blood

415

3624

1.23

2.78

4.0

5.2

0.17

0.21

e9/l

5.16

351

3143

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.94

2.77

1.3

2.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

217

0.36

2.67

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

2.17

2.62

1.1

1.3

1158.57

1734.46

e6/l

0.58

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

163

1285

1.31

2.57

3.0

2.6

1.64

1.16

e6/l

1.17

750

(1002224) Polysomnography panel

228

0.39

2.56

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

110

819

1.38

2.53

6.0

3.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

382

1.55

2.50

1.4

1.6

1.44

1.54

g/l

0.37

325

(3012441) Differential panel - Pleural fluid

2.21

2.48

1.2

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

174

1393

1.29

2.45

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

130

1001

1.34

2.42

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1092

0.70

2.40

12.3

7.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

239

2826

0.80

2.33

2.7

3.1

2002.47

1876.69

ng/l

0.13

221

2419

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

407

0.53

2.32

1.4

1.9

—

(40768441) Liver Pathology biopsy report

3.23

2.31

1.1

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

423

1.49

2.30

2.3

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

405

0.53

2.28

1.0

1.3

—

46.95

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.77

2.27

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

2.24

0.0

1.2

—

227.00

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.11

2.23

1.1

1.4

23004.20

103779.66

e6/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1143

0.72

2.20

1.3

2.57

2.86

g/l

1.00

651

(3001019) Free T4 and TSH panel - Serum or Plasma

183

0.38

2.16

2.3

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

149

0.33

2.15

1.2

20.22

22.39

u/l

—

128

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.30

2.15

1.2

1.6

93.83

55.64

nmol/24h

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

336

2939

1.20

2.12

2.5

2.2

74.06

77.87

nmol/l

1.63

312

2530

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

168

1.75

2.09

1.5

2.0

87.41

86.47

0.07

163

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.02

2.07

3.0

3.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

716

1.36

2.06

3.5

2.5

4.52

4.53

kpa

0.00

680

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

4.02

2.04

1.0

1.1

30.00

36.40

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

186

1.69

1.99

1.4

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

127

1005

1.30

1.98

1.8

—

(3045788) Cell count panel - Pleural fluid

2.09

1.97

1.1

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

120

1.85

1.93

3.3

2.3

—

(3048689) Calprotectin [Mass/mass] in Stool

684

0.67

1.92

2.3

2.2

218.15

162.63

ug/g

0.67

531

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.87

1.86

1.9

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

1.85

0.0

15.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

198

0.45

1.85

1.3

1.9

58.67

43.37

nmol/l

—

188

(3043410) Blood group antigens tested for on Red Blood Cells

3.54

1.84

1.0

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

219

1866

1.21

1.80

2.0

1.8

1154.26

1154.51

nmol/l

0.00

183

1405

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

523

1.38

1.80

1.9

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

146

1.73

1.78

1.6

2.3

247.28

198.59

1.60

138

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

284

0.52

1.76

1.5

2.0

37.95

39.55

u/l

0.10

236

(3035880) pH of Pleural fluid

2.51

1.74

1.1

1.3

—

(3000012) Reticulocyte production index

111

1.82

1.69

2.0

1.9

—

(40761536) Microorganisms panel - Urine sediment

575

1.34

1.65

3.0

3.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

100

1.81

1.53

1.4

1.3

—

(3044889) 12 lead EKG panel

508

5471

0.87

1.53

4.7

4.2

—

(3049717) Cytology report of Urine Cyto stain

291

1.46

1.52

2.9

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

144

0.41

1.52

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

144

0.41

1.52

1.2

2.1

192.83

223.16

pmol/l

—

134

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

123

1489

0.81

1.49

1.5

1.6

2.19

1.30

mg/l

2.47

104

1142

(3042631) Mycobacterium sp identified in Specimen

1.82

1.47

2.6

2.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

215

0.51

1.46

1.2

1.1

—

8.10

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

102

1.78

1.45

5.3

6.9

11.98

12.09

mg/l

0.03

(3020891) Body temperature

362

1.40

1.45

4.5

4.8

—

(3021788) Differential panel - Synovial fluid

153

0.45

1.44

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

277

0.57

1.43

1.9

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

313

0.60

1.41

1.7

—

(3026008) Bacteria identified in Urine by Culture

267

2371

1.16

1.38

2.8

3.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

346

0.63

1.36

1.2

1.7

—

28.86

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

1.34

0.0

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.00

1.34

0.0

6.4

—

71.26

—

(3007853) Bacteria identified in Skin by Aerobe culture

111

911

1.24

1.34

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

1.31

0.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

779

0.76

1.30

1.3

1.4

—

(4034850) Laboratory test

305

0.62

1.29

16.9

11.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.36

1.29

4.3

4.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

158

0.50

1.25

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

158

1831

0.84

1.24

3.0

3.5

—

(21494755) Public health laboratory ask at order entry panel

360

0.66

1.22

1.2

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

141

0.49

1.21

1.0

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.31

1.19

1.7

1.2

53.50

61.67

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

1.16

0.0

1.1

—

36.03

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

1.16

0.0

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

152

0.52

1.14

1.1

—

(3019150) Specific gravity of Urine by Refractometry

157

1805

0.85

1.13

3.7

3.9

1.02

kg/l

0.13

286

(3051651) Icteric interference index of Serum or Plasma

2.01

1.12

9.4

2.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

162

0.55

1.09

1.0

1.2

3.53

4.02

mmol/l

—

151

(3013139) Helicobacter pylori Ag [Presence] in Stool

427

1.30

1.07

1.1

1.3

—

(3015736) pH of Urine

273

2998

0.88

1.04

3.6

3.4

6.09

5.85

0.44

150

(36660697) Celiac disease serology panel - Serum

473

0.73

1.03

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

251

0.63

1.02

2.2

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

113

1324

0.84

1.02

1.2

1.09

1.71

u/ml

0.87

354

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1.92

1.02

1.1

1.9

—

99.47

u/l

—

(3017569) Oxygen content in Arterial blood

1.89

1.01

2.7

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

537

0.75

0.99

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.98

0.0

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.98

0.0

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

0.98

0.0

1.7

—

44.01

—

(40761535) Cells panel - Urine sediment

722

0.79

0.96

2.7

3.0

—

(1616796) Gas panel - Central venous blood

166

1.46

0.95

2.3

4.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.77

0.94

1.7

1.6

77.33

92.86

umol/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

197

0.60

0.94

1.3

1.4

1.08

1.13

g/l

0.19

189

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

101

1.59

0.94

1.2

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

144

0.55

0.93

1.4

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.83

0.92

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

694

0.80

0.90

1.5

1.8

1.62

0.00

584

(3013512) EKG study

225

2478

0.89

0.90

4.3

4.1

—

(3015183) Erythrocyte sedimentation rate

2.07

0.89

1.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.07

0.89

1.2

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

381

3556

1.11

0.88

2.4

2.1

84.61

91.94

pmol/l

3.33

275

1880

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.91

0.88

1.3

2.3

—

(4200892) Spirometry reversibility

560

0.78

0.88

1.2

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.01

0.87

1.2

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

192

0.62

0.86

1.3

1.4

0.23

0.22

g/l

0.03

186

(3037467) Urinalysis macro (dipstick) panel - Urine

499

5253

0.91

0.84

4.3

4.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

112

0.53

0.83

3.3

3.4

—

(3045414) Leukocytes [Presence] in Urine

307

0.71

0.82

2.0

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.74

0.82

1.3

1.4

—

(3022621) pH of Urine by Test strip

552

0.79

0.80

2.8

3.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

242

1.33

0.79

4.8

4.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

346

3697

0.91

0.79

5.0

4.9

0.00

estimate

-0.00

604

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

1827.29

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.79

0.0

1.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

603

1.21

0.79

3.9

3.4

103.19

93.32

ng/l

0.32

514

(3003129) Base excess in Capillary blood by calculation

0.00

0.78

0.0

1.3

—

1.12

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.78

0.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.56

0.78

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.77

0.0

1.0

—

(3021589) Normoblasts [#/volume] in Blood

337

3147

1.10

0.77

12.6

8.4

0.00

e9/l

0.08

263

2547

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.00

0.76

0.0

1.1

—

68.15

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.61

0.75

2.0

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.85

0.73

1.1

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

142

1.42

0.72

1.2

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.93

0.70

1.6

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.93

0.70

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.93

0.70

1.6

2.6

—

(3024928) Oxygen saturation in Venous blood

186

1.35

0.70

3.3

2.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.64

0.68

2.3

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

192

0.67

0.68

1.7

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

467

4448

1.08

0.68

3.5

3.0

74.72

51.67

u/l

2.03

437

4031

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.52

0.66

1.0

1.67

1.56

g/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.58

0.65

1.1

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

235

0.72

0.64

3.3

3.2

0.99

0.82

nmol/l

0.42

181

(4094501) Cardiovascular stress test using bicycle ergometer

212

0.70

0.64

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

354

3744

0.92

0.63

3.5

3.6

0.00

0.01

estimate

0.50

593

(3035350) Ketones [Presence] in Urine by Test strip

351

3713

0.92

0.63

3.6

0.00

0.01

estimate

0.69

669

(3000034) Microalbumin [Mass/volume] in Urine

1.50

0.63

1.6

3.2

22.59

36.92

mg/l

—

(3022313) Gas panel - Capillary blood

401

0.79

0.61

2.3

3.5

—

(3044941) Cell count panel - Synovial fluid

137

0.65

0.61

1.0

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

520

0.82

0.60

2.2

3.5

3.61

1.82

mmol/l

1.17

374

(3028707) Methadone [Presence] in Urine by Screen method

1.57

0.60

1.4

2.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.60

0.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.60

0.0

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.60

0.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.60

0.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.60

0.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.60

0.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.60

0.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.60

0.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.00

0.59

0.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.59

0.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

1.57

0.58

1.1

1.2

40.40

37.37

mmol/l

—

(3014051) Protein [Presence] in Urine by Test strip

208

0.72

0.58

3.0

2.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.58

0.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.58

0.0

1.4

—

(3044927) Protein electrophoresis panel - Urine

114

0.61

0.58

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

352

0.79

0.56

1.1

1.2

213.36

125.11

iu/ml

—

141

(46235355) HIV 1 and 2 tests - Meaningful Use set

683

1.15

0.55

1.4

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1.45

0.55

1.1

1.9

84.62

89.90

0.67

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

873

1.13

0.55

2.7

3.2

252.05

291.76

ng/l

0.40

812

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.47

0.54

1.1

1.2

46.31

22.50

iu/l

1.06

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

170

0.70

0.53

1.2

1.9

27.28

12.08

mg/l

0.45

156

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

341

1.21

0.53

1.8

1.7

—

(3052851) Hemolysis interference index of Serum or Plasma

241

1.25

0.52

4.4

3.4

—

(3011648) Oxygen content in Venous blood

1.52

0.52

1.5

1.9

9.10

10.63

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1.45

0.52

1.2

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.45

0.52

1.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

315

1.21

0.51

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.47

0.50

1.2

12.33

10.19

u/l

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

325

3417

0.93

0.50

3.6

4.1

30.19

75.58

ng/l

2.20

264

2571

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

110

0.63

0.48

1.0

1.1

—

14.32

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

155

1.30

0.47

1.2

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

276

0.79

0.46

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

147

1.30

0.45

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

175

0.74

0.45

1.4

1.5

0.70

0.77

nmol/l

0.19

143

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1.40

0.44

1.2

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

186

1738

1.08

0.44

3.5

4.2

613.43

507.77

ng/l

0.09

157

1490

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.37

0.43

1.2

1.3

—

(3003181) Sodium [Moles/volume] in Urine

148

1.29

0.43

1.4

58.07

63.06

mmol/l

0.25

116

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

104

1.35

0.43

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.1

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.43

0.42

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.56

0.42

1.0

1.3

122.00

166.27

mmol/24h

—

(3019225) pH of Specimen

776

1.12

0.42

4.0

3.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

173

0.75

0.42

3.2

2.4

2.14

1.69

mg/l

0.48

151

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.41

0.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

4.88

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.41

0.0

1.5

—

(3011288) Drugs identified in Urine by Screen method

1.34

0.40

1.5

3.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

105

0.66

0.39

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.43

0.39

1.2

1.3

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.39

0.0

1.4

—

0.17

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

276

2891

0.94

0.38

3.9

3.8

—

(3017732) Neutrophils [#/volume] in Blood

467

1.14

0.38

3.7

3.2

4.75

5.29

e9/l

0.29

357

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.39

0.38

1.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.65

0.35

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.63

0.35

1.4

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.43

0.35

1.0

1.2

10.67

16.24

u/l

—

(3004451) EKG impression Narrative

1.43

0.35

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.62

0.35

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

319

0.84

0.34

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

200

0.80

0.34

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

1.29

0.33

1.1

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

251

0.83

0.31

1.1

—

(3023419) Bacteria identified in Sputum by Culture

142

0.77

0.30

3.4

2.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.71

0.30

1.1

—

(4146454) Self-monitoring of blood glucose

100

0.70

0.30

4.3

2.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

586

0.90

0.29

1.3

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1.29

0.28

1.3

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.25

0.27

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.25

0.27

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

159

1.20

0.27

1.8

2.5

12.17

16.52

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.68

0.26

1.0

1.1

122.60

114.45

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.67

0.26

1.4

1.2

7.10

7.85

mmol/l

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

254

1.15

0.25

3.2

2.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

340

0.88

0.25

1.2

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

910

0.93

0.24

2.3

2.5

4.61

7.44

ug/l

1.43

783

(3051611) Lipemic interference index of Serum or Plasma

1.19

0.24

8.6

3.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

200

0.85

0.22

1.2

1.4

—

(3000494) Fungus identified in Specimen by Culture

847

1.07

0.21

1.5

1.4

—

(3036603) Volume of Urine

1.19

0.21

2.2

1.4

1830.00

1715.33

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.00

0.21

0.0

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

(3016228) CD19 cells/100 cells in Blood

0.00

0.21

0.0

1.6

—

4.91

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.21

0.0

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.21

0.0

1.4

—

(3019174) dRVVT (LA screen)

0.00

0.21

0.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.21

0.0

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.23

0.21

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

7.55

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.21

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

103

0.78

0.21

1.1

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.58

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

1.3

—

(3024932) HLA-DR beta [Type]

0.00

0.21

0.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.21

0.0

4.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.20

0.0

1.1

—

(3024471) HLA-A [Type]

0.00

0.20

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.9

—

16.46

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

207

0.87

0.19

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

207

0.87

0.19

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

132

0.83

0.18

1.2

1.6

—

(3021901) Oxygen saturation in Capillary blood

166

1.15

0.18

1.9

2.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

101

1.19

0.16

1.2

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

101

1.19

0.16

1.2

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

1.14

0.16

1.1

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

1.14

0.16

1.1

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

187

1.13

0.16

2.0

2.1

112.20

133.79

g/l

2.39

137

(3029937) Albumin [Presence] in Urine by Test strip

210

2042

1.03

0.16

3.2

3.9

0.00

0.01

estimate

0.50

578

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.78

0.15

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.14

0.15

1.1

1.4

—

nmol/l

—

(3045424) Erythrocytes [Presence] in Urine

0.80

0.14

1.6

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

202

0.89

0.14

4.1

3.3

59.62

27.98

mg/l

1.34

137

(3037756) Immunofixation for Serum or Plasma

160

0.87

0.14

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

212

0.89

0.14

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

107

0.84

0.13

1.0

1.4

—

(40768443) Skin Pathology biopsy report

252

0.91

0.12

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1.18

0.12

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

116

0.86

0.12

1.1

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

209

0.91

0.11

1.2

1.1

—

(3025941) Bacteria identified in Stool by Culture

348

1.07

0.10

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

508

5027

1.02

0.10

4.4

7432.30

2564.74

e6/l

—

101

(3032773) Endomysium IgG Ab [Titer] in Serum

1.14

0.10

1.4

1.1

—

(3045716) Anion gap in Serum or Plasma

1.04

0.09

2.2

1.4

7.60

10.67

mmol/l

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

1.3

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

0.79

0.08

1.0

322.20

283.67

mg/l

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.07

0.07

1.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.03

0.07

1.1

1.3

—

(3016879) Cocaine [Presence] in Urine

0.88

0.06

1.4

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

121

0.91

0.06

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

307

1.04

0.05

1.2

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

130

0.92

0.04

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

615

1.03

0.04

5.7

2.3

64.02

63.15

ml/min/173m2

0.06

251

(3000330) Specific gravity of Urine by Test strip

453

0.97

0.04

6.1

3.3

—

(3000764) Benzodiazepines [Presence] in Urine

1.09

0.03

1.3

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

208

0.96

0.02

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1.06

0.01

1.3

1.9

—

(3027008) Opiates [Presence] in Urine

1.06

0.01

1.3

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

154

1.04

0.00

1.4

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

192

1913

1.00

0.00

3.6

3.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

186

0.97

0.00

1.4

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

534

1.01

0.00

1.3

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.01

0.00

1.2

1.3

—

(3037121) Protein [Mass/volume] in Urine

271

1.00

0.00

2.0

2.5

0.24

0.26

g/l

0.06

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

563

0.99

0.00

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

4.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.6

—

(3027944) Amphetamines [Presence] in Urine

0.98

-0.00

1.3

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

3.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3051339) Copper [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

16.22

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

-0.00

0.0

14.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.91

-0.00

2.4

3.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.5

—

2.17

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

23.62

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

13.20

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

-0.00

0.0

2.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

104.40

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

-0.00

0.0

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.95

-0.00

1.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_STOMACH_ADENO – Adenocarcinoma and papillary adenocarcinoma of stomach

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenocarcinoma and papillary adenocarcinoma of stomach

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints